A month has gone by since the last earnings report for Paychex (PAYX - Free Report) . Shares have added about 14.4% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Paychex due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Paychex's Q4 Earnings:Paychex, Inc. reported solid fourth-quarter fiscal 2026 results, with adjusted earnings beating the Zacks Consensus Estimate and revenues coming in line. Adjusted earnings of $1.32 per share surpassed the consensus estimate of $1.31 by a slight margin and increased 10.9% from the year-ago quarter. Total revenues of $1.61 billion rose 12.5% year over year and beat the consensus estimate by a slight margin.
The earnings upside was backed by segment growth, Paycor contributions and disciplined expense performance. Management Solutions led the quarter, while PEO and Insurance Solutions, and client fund interest added further support.
PAYX's Management Solutions Powers GrowthManagement Solutions’ revenues increased 14% year over year to $1.18 billion in the fiscal fourth quarter. The segment benefited from higher product penetration and growth in client worksite employees within Human Resources Solutions.
Paycor, acquired in April 2025, contributed about 8 percentage points to Management Solutions revenue growth. The acquisition also supported price realization and higher revenues per client, reflecting Paycor’s upmarket client base.
Management noted that the quarter included a full period of Paycor revenues and expenses compared with a partial period in the prior-year quarter. That comparison helped drive the sharper contribution from the acquired business in the latest quarter.
Paychex's PEO & Client Funds Add SupportProfessional Employer Organization and Insurance Solutions revenues were $369.7 million, up 9% from the year-ago quarter. Growth in the number of average PEO worksite employees supported the segment’s performance.
PEO insurance revenues also increased during the quarter. Interest on funds held for clients rose 15% to $52.2 million, driven by higher average investment balances resulting from the Paycor acquisition.
Total service revenues came in at $1.55 billion, up 12% from the year-ago period. The broad advance across core services showed that growth was not confined to one operating line.
PAYX's Margin Profile Expands in Q4Total expenses were relatively flat year over year at $1 billion. Increases in compensation-related expenses, amortization of intangible assets, technology investments, selling initiatives and marketing spending were offset by lower acquisition-related compensation and professional service costs.
Operating income rose 40% to $604.7 million. The operating margin expanded to 37.7% from 30.2% a year earlier, while the adjusted operating margin improved to 42.1% from 40.4%.
Adjusted operating income increased 17% to $675.8 million. The adjusted figure excludes acquisition-related costs, which were lower than in the prior-year quarter.
Paychex's Profitability Shows Earnings LeverageNet income increased 41% year over year to $420.6 million in the fiscal fourth quarter. Diluted earnings were $1.17 per share, up 43% from the prior-year period.
Adjusted net income rose 10% to $474.6 million. EBITDA increased 39% to $719.1 million, while adjusted EBITDA advanced 17% to $729.7 million, reflecting revenue gains and reduced acquisition-related drag.
Interest expenses increased to $64.7 million from $63.7 million. Other income, net, declined to $14.2 million from $21.9 million due to lower average balances on corporate investments and higher share repurchases in fiscal 2026.
PAYX's Balance Sheet Remains SolidPaychex ended fiscal 2026 with cash, restricted cash and total corporate investments of $1.2 billion. Short-term and long-term borrowings, net of debt issuance costs, totaled $4.6 billion as of May 31, 2026.
Cash flow from operations was $2.6 billion for the fiscal year. The company paid out cumulative dividends of $4.43 per share, totaling $1.6 billion, and repurchased 5.6 million shares for $611 million.
Fiscal 2026 total revenues increased 17% to $6.51 billion. Adjusted diluted earnings advanced 11% to $5.51 per share, whereas adjusted operating income grew 19% to $2.81 billion.
Paychex's FY27 View Points to GrowthFor fiscal 2027, Paychex expects total revenues to grow 5-6%. Management Solutions’ revenues are also projected to rise 5-6%, while PEO and Insurance Solutions revenues are expected to increase 6-7%.
Interest on funds held for clients is expected to be $195-$205 million. The company anticipates an adjusted operating margin of 44%, an effective income tax rate of 24% and adjusted diluted earnings growth of 7-9%.
Paychex also highlighted the launch of WISE, its AI-powered intelligence engine, across HCM platforms and internal operations. Management said that the platform is designed to unlock insights from unstructured data, increase productivity and enhance client outcomes.
Adjusted earnings of 99 cents per share beat the Zacks Consensus Estimate by 4.2% and increased 8.8% on a year-over-year basis. Total revenues of $1.2 billion also beat the Zacks Consensus Estimate by 0.5% and increased 7.4% year over year.
Revenues in Detail
Revenues from Management Solutions segment increased 8% year over year to $895.3 million. The segment benefited from growth in the number of client employees served for human capital management (HCM) and additional worksite employees for HR Solutions. Also, improved revenue per client on price realization and higher product penetration, strong demand for HR Solutions, retirement, time and attendance solutions and expansion of HCM ancillary services acted as tailwinds.
Professional employer organization (“PEO”) and Insurance Solutions’ revenues were $273.3 million, up 4% from the year-ago quarter’s level. The uptick was owing to growth in the number of average worksite employees. Interest on funds held for clients increased 54% year over year to $21.7 million.
Operating Performance
Operating income increased 7% year over year to $472.3 million. EBITDA of $518.6 million increased 4.7% year over year.
Balance Sheet & Cash Flow
Paychex exited second-quarter fiscal 2022 with cash and cash equivalents of $1.1 billion compared with $1.18 billion reported at the end of the prior quarter. Long-term debt was $797.9 million compared with $797.8 million in the prior quarter. Cash provided by operating activities was $321.6 million in the reported quarter. During the reported quarter, PAYX paid out $284.7 million as dividends.
Fiscal 2023 View Tweaked
Paychex upped its adjusted earnings per share view with respect to year-over-year growth for fiscal 2023. Adjusted EPS is now expected to register 12-14% growth compared with the prior expectation of 11-12% growth. PAYX continues to expect total revenues to register 8% (prior view: 7-8%) growth. Management Solutions’ revenues are expected to grow 7-8% (prior view: 5-7%). PEO and Insurance Solutions’ revenues are expected to grow 5-7% (prior view: 8-10%).
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
VGM ScoresAt this time, Paychex has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. Charting a somewhat similar path, the stock has a grade of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Paychex has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Key Takeaways GEHC is expected to post healthy Q2 revenue growth, backed by imaging, diagnostics, and services demand.GEHC faces margin pressure from inflation, freight, tariffs, and higher input costs despite pricing actions.GEHC expects stronger second-half performance as efficiencies, pricing, and new products gain traction. GE HealthCare Technologies Inc. (GEHC - Free Report) is scheduled to report second-quarter 2026 results on July 29, before market open.
In the last reported quarter, the company’s adjusted earnings per share (EPS) of 99 cents missed the Zacks Consensus Estimate by 7.48%. The company beat on earnings in three of the trailing four quarters and missed once, delivering an average surprise of 2.90%.
Let’s check out the factors that might have shaped GEHC’s performance prior to the announcement.
Factors Likely to Have Driven GEHC’s Q2 PerformanceGE HealthCare is expected to have delivered another quarter of healthy revenue growth, supported by resilient global demand for imaging equipment, continued strength in Pharmaceutical Diagnostics (PDx), and robust services performance. On its first-quarter earnings call, management had maintained its full-year organic revenue growth outlook of 3-4%, citing healthy order trends, a record $21.8 billion backlog, strong book-to-bill, and improving commercial execution despite a cautious view on China.
However, profitability is likely to have remained under pressure from elevated inflation in memory chips, freight, oil and commodity costs, with management already guiding for low-single-digit adjusted EPS decline in the second quarter before improvement in the second half.
Following the organizational restructuring, the newly created Advanced Imaging Solutions business is likely to have benefited from sustained demand for CT, X-ray, ultrasound and visualization products. Imaging demand should have been supported by Revolution Vibe cardiac CT systems, while Advanced Visualization Solutions likely continued to benefit from adoption of products, such as Vivid Pioneer and other AI-enabled platforms. Although Photonova Spectra photon-counting CT generated encouraging customer interest after regulatory approvals, revenue contribution is unlikely before 2027 due to typical installation timelines.
Pharmaceutical Diagnostics is likely to have remained the company's strongest-performing business. Continued growth in contrast media, radiopharmaceuticals and molecular imaging, along with accelerating Flyrcado adoption and increasing Vizamyl demand driven by Alzheimer's imaging, likely supported another solid quarter. However, planned investments in the radiopharmaceutical pipeline and integration of recent acquisitions may have weighed on margin expansion.
Patient Care Solutions likely remained the weakest segment, although management expects gradual improvement later in the year as large monitoring installations convert from backlog and the premium anesthesia platform approaches regulatory clearance. Lower first-half volume and ongoing tariff-related costs probably continued to weigh on segment profitability.
On the margin front, the second quarter is expected to represent the peak impact from inflationary input costs, including memory chips and freight, while pricing actions and cost mitigation initiatives are likely to have provided only limited near-term relief because much of the second-quarter revenues probably originated from existing backlog. Adjusted EBIT margin and EPS are expected to have remained pressured, with a stronger recovery anticipated during the second half as pricing actions, operating efficiencies and new product momentum begin to offset inflationary pressures.
GEHC’s Estimate PictureFor second-quarter 2026, the Zacks Consensus Estimate for revenues is pegged at $5.25 billion, implying an improvement of 5% from the prior-year quarter’s reported figure.
The consensus estimate for EPS is pegged at $1.04, indicating a decrease of 1.9% from the prior-year period’s reported number.
What Our Model Suggests for GE HealthCarePer our proven model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you will see below.
Earnings ESP: GE HealthCare has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank stocks here.
GEHC’s Share Price PerformanceSo far this year, GE HealthCare’s shares have lost 24.4% compared with the industry’s 22.5% decline. The S&P 500 has gained 9.2% during the said period.
Image Source: Zacks Investment Research
Stocks Worth a LookHere are some stocks from broader medical sector worth considering, as these have the right combination of elements to post an earnings beat this reporting cycle.
Cardinal Health (CAH - Free Report) has an Earnings ESP of +1.24% and a Zacks Rank #2 at present. The company is set to release fourth-quarter fiscal 2026 results on Aug. 11. You can see the complete list of today’s Zacks #1 Rankstocks here.
CAH’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 10.27%. The Zacks Consensus Estimate for CAH’s fourth-quarter EPS indicates an improvement of 16.4% from the year-ago reported figure.
Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.41% and a Zacks Rank of 2 at present. The company is scheduled to release second-quarter 2026 results on Aug. 4.
HSIC’s earnings surpassed estimates in three of the trailing four quarters and missed once, with the average surprise being 3.74%. The Zacks Consensus Estimate for HSIC’s second-quarter EPS implies an improvement of 10.9% from the year-ago reported figure.
Agilent Technologies (A - Free Report) has an Earnings ESP of +1.02% and a Zacks Rank of 3 at present.
A’s earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 1.61%. The Zacks Consensus Estimate for A’s third-quarter fiscal 2026 EPS reflects an improvement of 8% from the year-ago reported figure.
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Steven Madden (SHOO - Free Report) , which belongs to the Zacks Shoes and Retail Apparel industry, could be a great candidate to consider.
This footwear and accessories retailer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.75%.
For the most recent quarter, Steven Madden was expected to post earnings of $0.42 per share, but it reported $0.45 per share instead, representing a surprise of 7.14%. For the previous quarter, the consensus estimate was $0.46 per share, while it actually produced $0.48 per share, a surprise of 4.35%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Steven Madden. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Steven Madden has an Earnings ESP of +13.68% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 30, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Key Takeaways PHM beat Q2 earnings and revenue estimates, though both declined from the prior year.PHM's $131 target offers modest upside as shares trade above key homebuilding valuation benchmarks.Buybacks and low leverage support PHM, but 2026 earnings and revenues are projected to fall. PulteGroup, Inc. (PHM - Free Report) gave investors a mixed second-quarter readout. Earnings and revenues topped expectations, but both fell from the prior year as closings, pricing and margins weakened.
The investment case now rests on balance. PHM offers capital returns, a solid balance sheet and modest price-target upside, but growth estimates and margins remain under pressure.
PHM Beats Estimates Despite Lower EarningsAdjusted earnings were $2.48 per share, topping the Zacks Consensus Estimate of $2.38 by 4.2%. Total revenues of $3.983 billion edged past the consensus mark of $3.980 billion by 0.1%.
The beat did not erase the year-over-year decline. Earnings fell 18.2% from $3.03 per share, while total revenues decreased 9.6% as lower closings and softer average selling prices weighed on results.
PulteGroup’s Valuation Offers Limited UpsidePHM’s $131 price target compares with a reported share price of $124.67, leaving only modest potential appreciation. That limits the valuation argument, even though the company continues to generate orders and return capital.
The stock traded at 11.85 times forward earnings, above the sub-industry’s 10.88 multiple and PHM’s five-year median of 8.33. It still traded well below the broader construction sector and the S&P 500, keeping the valuation picture mixed rather than clearly cheap.
D.R. Horton (DHI - Free Report) and Lennar Corporation (LEN - Free Report) remain relevant comparisons because both operate as national homebuilders facing similar affordability and margin pressures. D.R. Horton describes itself as the largest U.S. homebuilder by volume, while Lennar is commonly tracked alongside DHI and PHM in homebuilding comparisons.
PHM’s Forecasts Point to a Difficult 2026Current projections call for 2026 revenues of $16.404 billion, down from $17.312 billion in 2025. Expected earnings are $10.01 per share, compared with $11.44 in 2025.
Estimates point to improvement in 2027, with revenues projected at $17.045 billion and earnings at $11.09 per share. The timing and durability of that recovery are central to whether PHM’s valuation can become more appealing.
PulteGroup Returns Capital While Funding GrowthPHM repurchased 3.1 million shares for $373 million in the second quarter. First-half repurchases totaled 5.5 million shares, or roughly 3% of outstanding shares, for $681 million.
The company maintained a quarterly dividend of 26 cents per share and had $1.8 billion remaining under its repurchase authorization. It is also funding land investment, though first-half operating cash flow fell to $176.8 million from $421.7 million as inventories increased.
PHM’s Balance Sheet Limits Financial RiskPulteGroup ended June with $1.38 billion in cash, cash equivalents and restricted cash. Its debt-to-capital ratio was 12.3%, while net debt-to-capital was 3.3%, giving the company financial flexibility in a softer housing cycle.
The land pipeline also supports flexibility. PHM controlled about 228,000 lots, with 55% held through option agreements, limiting upfront ownership exposure when demand is uncertain.
PHM’s Scores Support a Selective ApproachThe bottom line is that PHM looks more balanced than broadly attractive. The earnings beat, buybacks and balance sheet help, but declining estimates and margin compression keep the risk-reward selective.
PHM currently carries a Zacks Rank #2 (Buy), with a Value Score of B, Momentum Score of B and VGM Score of B. Those grades provide positive near-term signals, while the Growth Score of D reflects weaker projected earnings and sales trends. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock may suit investors focused on disciplined capital returns and balance-sheet strength. Investors prioritizing immediate growth may need clearer evidence that earnings, revenues and margins are stabilizing.
Key Takeaways PulteGroup's wider community base lifted second-quarter net new orders 6.4% to 7,536 homes.Build-to-order homes rose to 45% of orders as PulteGroup cut spec homes in production 13%.PulteGroup's gross margin fell 200 basis points to 25.0% as incentives reached 10.4% of prices. PulteGroup (PHM - Free Report) is widening its community base to support orders across first-time, move-up and active-adult buyers. That broader reach is helping offset ofter affordability conditions.
The trade-off is clear. Closings, average selling prices and margins remain under pressure, making inventory discipline central to PHM’s near-term execution.
PulteGroup’s Community Growth Supports New OrdersSecond-quarter net new orders increased 6.4% year over year to 7,536 homes. The gain came as average community count rose 8% to 1,074.
Absorption slipped 1% to 2.3 homes per community per month. That suggests community expansion, rather than stronger demand at each location, remains the main volume driver.
PHM Shifts Back Toward Build-to-Order HomesPulteGroup is moving back toward its long-term mix of 60% build-to-order homes and 40% spec homes. Build-to-order properties represented 45% of second-quarter orders, up from 40% a year earlier.
The shift is helping reduce inventory risk. Spec homes in production declined 13% to 6,638, while finished spec inventory fell to about 1.3 homes per community.
PulteGroup Reaches Multiple Buyer SegmentsPulteGroup’s second-quarter orders were balanced across buyer groups: 39% first-time, 36% move-up and 25% active adult. That mix reduces reliance on one customer category.
Orders increased across all three groups. Active-adult orders rose 12%, while first-time and move-up orders advanced 5% and 4%, respectively.
PHM Uses Geographic Scale to Manage VolatilityOrders rose in every region except the West, led by 19% growth in Florida. Demand was also favorable in several Midwest markets, Greenville and the Coastal Carolinas.
This geographic breadth gives PulteGroup room to adjust incentives, inventory and capital by local market. Peers such as D.R. Horton (DHI - Free Report) and Lennar Corporation (LEN - Free Report) face similar affordability and pricing trade-offs, making local scale an important competitive lever across the homebuilding group.
PulteGroup Faces Persistent Margin PressureHome sale gross margin declined 200 basis points year over year to 25.0%. Incentives equaled 10.4% of gross selling prices, up from 8.7% a year earlier.
Lower closings and a softer average selling price weighed on revenues, while selling, general and administrative expenses rose as a percentage of home sale revenues. Higher lot costs also remain a risk, even if lower construction costs provide some offset.
PHM’s Ratings Reflect Balanced Near-Term SignalsThe bottom line is that PulteGroup is generating orders through broader market coverage and tighter inventory control, but affordability pressure is still limiting operating leverage. The setup is resilient, not risk-free.
PHM currently carries a Zacks Rank #2 (Buy), indicating a favorable short-term earnings-revision signal. The stock also has a Value Score of B, Momentum Score of B and VGM Score of B, which support a constructive near-term profile. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Growth Score of D keeps the outlook mixed. Projected declines in earnings and sales suggest investors should balance PHM’s order resilience against ongoing margin and demand pressure.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Huntington Ingalls (HII - Free Report) . This company, which is in the Zacks Aerospace - Defense industry, shows potential for another earnings beat.
When looking at the last two reports, this shipbuilder has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 5.52%, on average, in the last two quarters.
For the most recent quarter, Huntington Ingalls was expected to post earnings of $3.7 per share, but it reported $3.79 per share instead, representing a surprise of 2.43%. For the previous quarter, the consensus estimate was $3.72 per share, while it actually produced $4.04 per share, a surprise of 8.60%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Huntington Ingalls. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Huntington Ingalls currently has an Earnings ESP of +0.53%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 30, 2026.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
IMAX Corp (NYSE:IMAX) received a price target increase from Wedbush to $54 from $46, with the firm reiterating its Outperform rating as it expects continued growth from a stronger film pipeline, market share gains and global expansion.
The analysts wrote that IMAX remains on Wedbush’s Best Ideas List as the company benefits from an increase in the volume and quality of films produced for IMAX, a broader mix of local-language and global releases, expanded alternative content offerings and further international footprint growth.
“IMAX remains on Wedbush’s Best Ideas List given our view that it is benefitting from an uptick in volume and quality of filmed-for-IMAX titles in the second half of 2026 through 2028, which is driving market share gains,” the analysts wrote.
Wedbush highlighted IMAX’s second-quarter results as evidence of the strength of its business model, noting that the company exceeded expectations despite weaker Chinese box office performance and a modest domestic share decline during a quarter with a heavier focus on family films.
“IMAX’s results demonstrated the quality of its business model that handily beat expectations despite a shortfall in its Chinese box office and a modest domestic share loss in a quarter heavier on family fare,” the analysts wrote.
IMAX reported second-quarter revenue of $103 million, up 12% year over year and above Wedbush’s and consensus estimates of $94 million. Adjusted EBITDA came in at $45 million, ahead of Wedbush’s estimate of $39 million, driven by higher installations, improved margins and operating expense leverage.
The analysts wrote that additional installations during the quarter supported results and helped ease concerns around IMAX’s ability to reach its 2026 box office target of $1.4 billion, given the strength and diversity of its upcoming release slate.
Wedbush also highlighted IMAX’s profitability outlook, writing that the company’s target of achieving EBITDA margins above 45% in 2026 and surpassing 50% by 2028 now appear conservative.
“IMAX’s 45% plus EBITDA margin target for 2026 and guidance to surpass 50% EBITDA margins by 2028 now appear conservative,” the analysts wrote.
Looking ahead, Wedbush wrote that the next phase of IMAX’s growth story will focus on improving the timing and flow of major film releases. The analysts noted that while 2026 includes several major IMAX titles, including The Odyssey and Dune 3, a crowded release schedule has limited the ability of studios and IMAX to maximize overall box office performance.
“Focus will now shift to the next leg of IMAX’s growth story: better orchestrating the flow of the annual release slate,” the analysts wrote.
Wedbush wrote that the 2027 release schedule already appears less crowded, as IMAX has become an increasingly important partner for studios across genres, languages and geographies. The analysts added that improved release timing, market share gains and international expansion provide additional opportunities for growth.
The revised $54 price target is based on a 13 times enterprise value-to-EBITDA multiple applied to Wedbush’s updated 2028 EBITDA estimate, compared with a previous 12 times multiple. It also implies upside from current levels of about $45.
Wedbush also noted potential upside if IMAX were to attract acquisition interest, writing that the company’s combination of a globally recognized premium brand, an asset-light licensing model and a structurally expanding earnings profile could make it attractive to a potential buyer.
Key Takeaways Humana is expected to post strong Q2 revenue growth driven by higher premiums and Medicare expansion.HUM's rising Insurance and CenterWell operating income support earnings beat hopes.Higher opex, weaker investment income and a rising benefits expense ratio may partially offset positives. Humana Inc. (HUM - Free Report) is set to report second-quarter 2026 results on July 29, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $6.22 per share on revenues of $40.65 billion.
The second-quarter earnings estimate has witnessed three upward revisions and no movement in the opposite direction over the past 60 days. However, the bottom-line projection indicates a year-over-year decrease of 0.8%. Yet, the Zacks Consensus Estimate for quarterly revenues implies year-over-year growth of 25.5%.
Image Source: Zacks Investment Research
For full-year 2026, the Zacks Consensus Estimate for Humana’s revenues is pegged at $162.60 billion, implying a rise of 25.3% year over year. However, the consensus mark for current-year EPS is pegged at $9.25, implying a plunge of around 46% on a year-over-year basis.
HUM’s earnings beat the consensus estimate in three of the trailing four quarters and missed once, with the average surprise being 3.8%.
Q2 Earnings Whispers for HUMOur proven model predicts a likely earnings beat for the company this time around as well. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is precisely the case here.
Humana has an Earnings ESP of +1.71% and a Zacks Rank #1. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping HUM’s Q2 Results?The Zacks Consensus Estimate for HUM’s second-quarter premiums indicates a 25.6% increase from the prior-year quarter’s reported figure, whereas our model predicts 24% growth. We expect total Medicare to witness 26.6% growth in the quarter under review. Similarly, the consensus mark for service revenues signals a 22.3% increase from a year ago, whereas our model predicts a nearly 16% jump.
Also, the Zacks Consensus Estimate for insurance membership predicts a 18.2% year-over-year growth, whereas specialty membership is expected to rise 3.7%.
The Zacks Consensus Estimate for operating income from the Insurance unit indicates 10.2% growth from a year ago. The same for the CenterWell unit predicts a 12.8% growth from the year-ago level. The above-mentioned factors are expected to have positioned the company for an earnings beat in the second quarter.
However, the consensus estimate indicates that Humana’s investment income will see a 13.5% drop from the year-ago level. We expect total operating costs to increase 24.4% in the second quarter, bringing the figure above $38.9 billion. This is likely to have led to a year-over-year decline in the bottom line.
The consensus mark for insurance benefits expense ratio is pegged at 91.3% for the to-be-reported quarter, deteriorating from 89.9% a year ago. These are likely to have partially offset the positives.
How Did Peers Perform?Several healthcare companies, including UnitedHealth Group Incorporated (UNH - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Elevance Health, Inc. (ELV - Free Report) , have already reported their financial results for the June quarter of 2026. Here’s how they performed:
UnitedHealth reported second-quarter 2026 adjusted EPS of $6.38, which beat the Zacks Consensus Estimate of $4.94. The bottom line rose 56.4% year over year. Its strong quarterly results were aided by growth in commercial fee-based membership and the strength witnessed in Optum Insight. Medical cost management, pricing discipline and benefit design changes also contributed to the upside. However, weakness in UNH’s Optum Health, Optum Rx and declining risk-based membership partially offset the positives.
Molina reported second-quarter 2026 adjusted EPS of $1.51, which beat the Zacks Consensus Estimate by 10.2%. But the bottom line declined 72.4% from the year-ago period's level. MOH’s earnings benefited from lower operating expenses. However, lower premium revenues, declining membership, and weaker investment income weighed on its performance.
Elevance reported second-quarter 2026 adjusted EPS of $7.45, which surpassed the Zacks Consensus Estimate by 20.6%. However, the bottom line declined 15.7% year over year.The quarterly results were primarily driven by higher premium yields in the Health Benefits segment and increased CarelonRx product revenues. The upside was partly offset by a decline in ELV’s overall medical membership and an elevated expense level.
The Board of Directors of ArcBest (Nasdaq: ARCB) has declared a quarterly cash dividend of twelve cents ($0.12) per share to holders of record of its Common
Lien Finance has lost about $542,000 in USDC after an attacker exploited a flaw in its bond token logic to mint unsupported assets and drain liquidity from the protocol.
Summary
Lien Finance lost about $542,000 in USDC after attackers exploited a flaw in its bond token exchange logic. Security researchers said the exploit allowed unsupported bond tokens to be minted and exchanged for real liquidity from the protocol. The incident adds to a series of DeFi exploits this month as researchers continue to examine weaknesses in protocol pricing and validation logic. Blockchain security firm SlowMist said the exploit targeted Lien Finance’s bond exchange mechanism, allowing the attacker to create bond tokens without destroying the corresponding input bonds before swapping them for USDC. The firm estimated the loss at roughly 542,144.63 USDC and identified the attacker wallet as 0x0d7d…1808a.
🚨SlowMist TI Alert🚨
💸 @LienFinance Loss: ~542k USD
🔍 Root Cause: The `exchangeEquivalentBonds` function in BondMakerCollateralizedEth lacks proper multiset integrity checks. It only counts total exception occurrences instead of verifying each bondID's appearance per group.…
— SlowMist (@SlowMist_Team) July 24, 2026 According to SlowMist, the vulnerability was located in the exchangeEquivalentBonds function of the BondMakerCollateralizedEth contract. Its analysis said the function failed to properly verify the integrity of bond groups during exchanges. Instead of checking whether every bond ID appeared the required number of times, the contract counted only the total number of exception entries. By repeatedly using the same exception bond ID in the output group, the attacker satisfied the validation logic while omitting another required bond from the input.
SlowMist said the flaw allowed the attacker to mint new BondTokens that appeared valid even though no matching collateral had been consumed. The newly created assets were then exchanged for USDC through three pre-authorized endpoints, resulting in the withdrawal of about 542,144.63 USDC from the victim address 0xa961684a3a654fb2cca8f8991226c0cefc514d80.
The security firm identified the affected contracts as 0xda6fc5625e617bb92f5359921d43321cebc6bef0 and 0x843225cf6e663e4454732d6b551a737ac7b47de0.
Permissionless bond registration and pricing logic under scrutiny Separate on-chain analysis from DefimonAlerts, later amplified by researcher exvulsec, described the incident as a protocol logic failure that combined permissionless bond registration with pricing weaknesses inside Lien Finance’s over-the-counter bond pools.
🚨 @LienFinance – Loss $542K (2026-07-24)
Network: Ethereum
Type: Oracle / Price Manipulation
Lien Finance's GeneralizedDotc bond-to-ERC20 OTC pools were drained. An attacker-deployed orchestration contract (0xe74d17c1) permissionlessly registered new bond groups on the…
— Defimon Alerts (@DefimonAlerts) July 24, 2026 According to that analysis, the attacker first deployed an orchestration contract before registering a new bond group through the BondMakerCollateralizedEth contract. Because the registration process did not require governance approval, the attacker was reportedly able to introduce a bond group built around a malicious payoff function.
The report said the crafted bond tokens were then routed into Lien Finance’s GeneralizedDotc OTC pools. It pointed to the protocol’s internal _calcRateBondToErc20 function, saying it appears to have assigned excessive value to the newly created bonds despite their lack of genuine collateral backing.
As a result, the attacker exchanged what researchers described as effectively unsupported structured products for real USDC liquidity held in the protocol’s pools. The primary affected liquidity pool was the GeneralizedDotc contract at 0x656e…9ef18, while the attacker wallet received the proceeds through the main exploit transaction.
Researchers examining the exploit have described it as a protocol pricing and validation failure rather than a conventional smart contract exploit such as reentrancy or an access control bypass. According to the published analysis, the attack relied on introducing synthetic financial instruments whose economic value was not sufficiently validated before they became eligible for OTC swaps.
The researchers compared the incident with April’s Drift Protocol exploit, where attackers reportedly introduced fabricated collateral that the protocol accepted at inflated values before real assets were withdrawn. They noted that the two cases differ in implementation but share a similar pattern of exploiting valuation logic instead of breaking cryptographic protections.
Latest incident adds to a string of DeFi exploits The Lien Finance exploit comes during an active period for decentralized finance security incidents.
Just one day earlier, on-chain analytics platform Lookonchain described July 23 as “Hackers’ Day” after three separate exploits resulted in combined reported losses of about $35.55 million. Those incidents included a $24.15 million exploit involving AFX Trade’s bridge infrastructure, a $7.54 million attack on the Verus Ethereum Bridge, and a separate $3.86 million exploit affecting B² Network.
In the AFX incident, blockchain security firm Blockaid said attackers drained about $24.15 million in USDC from infrastructure operated by the protocol rather than Arbitrum’s native bridge. Offchain Labs separately confirmed that Arbitrum’s core bridge was not compromised and said the incident involved third-party infrastructure.
Meanwhile, Blockaid also linked the latest Verus Ethereum Bridge exploit to the same bridge contract, entry path and apparent bug class involved in the project’s May breach. The firm said the July attack generated unbacked Ethereum-side payouts through the bridge’s import process, although a complete technical explanation had not yet been published.
Earlier this month, Lazy Summer Protocol lost about $6.04 million in a share price manipulation attack, while Bonzo Finance on Hedera reported losses of around $9 million following an oracle-related exploit. Allbridge Core also suffered a flash-loan-driven stable pool attack that drained roughly $1.65 million, and Polychain-backed Cascade lost approximately $1.34 million in another exploit during July.
🚨Blockaid's exploit detection system has identified an ongoing exploit on @summerfinance_.
~$6M drained so far.
More details in 🧵
— Blockaid (@blockaid_) July 6, 2026 Researchers tracking decentralized finance attacks have estimated cumulative losses exceeding $630 million during the first seven months of 2026. Their data identifies oracle manipulation, pricing flaws, compromised credentials and bridge validation weaknesses among the most common attack vectors recorded this year.
BondMaker architecture has faced security issues before For long-time Ethereum developers, the latest exploit revisits an architecture that has drawn security attention before.
In September 2020, a white-hat group led by security researcher Samczsun prevented the loss of roughly $10 million after identifying a flaw in Lien Finance’s original BondMaker system.
Security researchers at the time said the earlier vulnerability allowed attackers to create empty bond groups that could be exchanged for properly collateralized ones through an equivalence function, making it possible to extract Ether without matching backing. The issue was intercepted before malicious actors could exploit it, and the recovery became one of Ethereum’s most prominent coordinated white-hat rescue efforts.
Unlike the 2020 incident, the latest exploit resulted in an actual loss after attackers used weaknesses in bond validation and pricing logic to withdraw USDC from live liquidity pools. At the time of publication, Lien Finance had not released a detailed technical postmortem or announced whether any of the stolen funds had been frozen or recovered.
Circle is facing criminal charges in Wisconsin because, in relation to some investment fraud, "Circle Internet Financial LLC has declined to repatriate the corresponding fiat reserves" and "Circle has not complied with a Circuit Court Judge’s seizure warrant."
Law enforcement secured a seizure warrant which Circle will not enforce. Circle claims they cannot enforce it. The government is charging Circle for declining to enforce it. Whatever is going on: everyone agrees Circle is not currently enforcing it.
This column has a long history of pulling entertaining and contradictory bits out of company public statements and (usually much later) legal settlements where those companies got caught doing something they were not supposed to do. Much of the time the company in question made explicit statements that it would not do the conduct it eventually admitted doing. And much of the time those public statements were contemporaneous with the bad conduct. But we only found out they were lying years later.
Here we have the rare opportunity to work through seemingly-false statements made by a company during a public dispute with law enforcement in real time. So that is what we are going to do. Some of this was covered by the ICIJ but we think their narrative is too generous towards Circle.
Some BackgroundTether routinely seizes funds for law enforcement. Tether has the power to transfer USDT out of your address and burn them without your knowledge or consent. So to seize funds Tether just burns tokens from anywhere and then issues fresh replacement USDT to whatever address law enforcement wants. In theory Tether could also take the funds back from law enforcement — the same process can be used for any address — though that has not yet happened. Tether has had these powers for many years. Nothing is this paragraph is new or controversial.
Circle is a little bit different. Circle does not currently have a seize function in their tokens. Both Tether and Circle can freeze funds – immobilizing them in an address – but Circle's current smart contracts do not support seizure. Circle routinely freezes tokens but it does not seize them. This is presumably what Circle was referring to when it told the Walworth County Circuit Court:
Beyond the ability to blocklist wallets, however, Circle has no control of USDC held in third-party wallets and has no ability to invalidate and reissue such USDC or to transfer them.The key words here are "has no control" and "has no ability." Circle uses the conjunction "and" meaning Circle believes both of those claims to be independently true. If Circle has any way to wrangle invalidation then Circle made a false statement to the court. Given invalidation we know reissuance is possible because once you invalidate the "bad" tokens the reissuance is just issuance. Which happens all the time. So the threshold question here is whether Circle can "invalidate" USDC in an address specifed by law enforcement.
Circle's PowersCircle cannot currently invalidate USDC and seize funds. But Circle can upgrade USDC to have whatever functionality it desires. So it cannot follow this roadmap to comply with a seizure order:
Seize the fundsBut absolutely it can comply with this roadmap:
Upgrade USDC to allow seizureSeize the fundsIn a strange turn, Circle told the government the required process to seize the funds was as follows. And bear in mind we are quoting Circle's own court filing here so this is presumably a generous phrasing from Circle's perspective:
Circle also communicated to Detective Kuchta that (1) the address was not held at Circle; (2) Circle did not have the private keys for the address; (3) Circle could not, therefore, transfer USDC from the wallet; and (4) to recover the USDC for the victim law enforcement would need to locate the private keys for the address. By telling the police to go find the private keys Circle is being, well, let's call it intransigent. Actually, no, let us be a bit more direct (with apologies to Andy Samberg and Justin Timberlake). Circle looks to prefer these steps:
Get charged for no function to seizeMoan how it sucks to seizePut in a function to seizeThat’s the way they do it. Circle is being a...go watch the video in that last link.
It is hardly a secret Circle can upgrade the USDC contracts so it looks pretty likely this capability will eventually come up in court and the judge will sort Circle out. Circle's terms also provide the company with incredibly broad discretion to deny anyone access at any time and in any manner at all for pretty much any reason. This text is in the Acceptable Use Policy describing a list of things you are not allowed to do with USDC and which might lead Circle to cut you off:
For clarity, the following lists are not exhaustive and we may, at our sole discretion, modify them without notice.So Circle can decide anything it likes is out of bounds. And that document covers:
services provided by Circle Internet Financial, LLC, Circle Payments, LLC, Circle UK TradingLimited and/or Circle International Bermuda Limited (together, “Circle”), inclusive of, but not limited to, Circle Mint account,Application Programming Interface products, card processing, and the Circle Yield offering (together and separately, the “Services”), The "but not limited to" would seem to provide sufficient cover to enforce a court order by including whatever corners of Circle's operation are needed to effect the required upgrades. Remember: in this case a court is telling Circle to do something and Circle is not doing it. Maybe you think reading that clause in such a broad manner is squirrely. Sure, maybe. But that is a problem when a strained reading is used to evade a court or the clear intent of a contract or some other agreement. In the present case not reading these powers broadly led to criminal charges and is, in a real and on-going sense, blocking enforcement of a court order. Using this ambiguity to comply with the court is not going to anger the court. Certainly not any more than the current behaviour will.
Circle's Terms vs. ActionsIn Circle's documentation the company anticipates that court orders may come in to request asset freezes. There is an Access Denial Policy which sets out the freeze framework. And there is even a section entitled "Blocked Addresses & Forfeited Funds" in the USDC Terms. That later section includes this text:
Circle may also be required to freeze USDC and/or surrender associated USD held in Segregated Accounts in the event it receives a legal order from a valid government authority requiring it to do so.This anticipates the idea that a court order may mandate sending USD somewhere the court directs. The word "forfeited" appears in a section heading. And if we look at the government's description in Wisconsin we find something very much on point:
The Court’s Warrant ordered Circle to “facilitate the seizure” of Victim #1’s USDC and invalidate that USDC so that it had no value. The Warrant then ordered Circle to issue approximately $381,000 in new USDC to compensate Victim #1 and transfer that new USDC to a digital wallet owned by the Walworth County Sheriff’s Department. This procedure is known as “burn and reissue”."Facilitate the seizure" is a broad directive. The court is not telling Circle precisely how to satisfy the court's desires. The court is simply saying "find a way to do this." And Circle's on-the-record response is weird. Above we quoted Circle's broad claim of "no ability." The government's narrative gives a bit more colour there too:
In subsequent discussions, Circle’s representatives have explained that the company holds approximately $381,000 in US Currency in reserve to cover the value of Victim #1’s USDC, even though that USDC cannot be redeemed by anyone for US Currency because Circle froze it. Circle protested that if it issued $381,000 worth of new USDC, it would also have to hold an additional $381,000 in US Currency to cover the new USDC. Circle objected that it would be unfair for the company to have to set aside that much US Currency in reserve. Circle also stated that by the terms of its own contracts, it will not “burn and reissue” USDC.This is some twisted logic. Circle seems to believe it is required to maintain backing for all USDC, frozen or not, and that because it currently cannot burn and reissue USDC this would require holding double reserves for the recovered amount and that – the double reserving Circle just imposed on itself – is unfair.
We will immediately concede that double reserving here is unreasonable and dumb. But the double reserving is only "required" if we accept Circle's claim it cannot do the burn and reissue. This is a strained attempt for Circle to look like the victim. Possibly so that Circle can continue to collect interest on the US$381,000 in reserves it holds against the frozen tokens
Said another way: Circle's protest assumes Circle will not use its power to upgrade the USDC to allow seizures. We know this is Circle's thinking because, again quoting the Wisconsin government:
Circle also stated that by the terms of its own contracts, it will not “burn and reissue” USDC.This is weird. The word "reissue" does not appear on circle.com, as of this writing, per a number of searches. And the USDC Risk Factors also include a section entitled "Blocked Addresses & Forfeited Funds" so this is puzzling. If we read the reference to "its own contracts" in that last quote from Circle as pertaining to the USDC smart contracts it is again true in a literal-and-useless sense. By the terms of the currently deployed smart contracts there is no reissue power. But by the terms of those same contracts Circle can simply change the contracts.
Circle looks to be playing games so it can collect interest on frozen USDC forever. Holding frozen scam-related funds forever and keeping the interest is an interesting business model.
ContractsIf you have ever entered into any sort of commercial agreement you have probably seen clauses that allow someone to modify the terms under extreme circumstances and maybe also in a "commercially reasonable manner" if the need arises. Most contracts contemplate the idea that things can change and some amount of flexibility is required. For example, a company may change its office address. Or it may change where it banks. Or any number of other things. If you enter into a contract which includes bank details and the other party changes where it banks that does not mean you automatically can stop paying. If the company tells you where to send the money instead you cannot just decide to terminate the contract (unless it is a very strange contract indeed).
Similarly, you might enter into a contract based on some published reference price – think oil or gold or a commercial property index or some interest rate benchmark – and the name of that thing might change. Or where or how it is published might change. Someone is supposed to keep things up to date in a commercially reasonable manner. There is standard verbiage for this in many industries and if you end up in court the judge will make you do the sensible thing. Yes there are corner cases. But the Circle mess is really quite simple. Circle's term look to allow for enforcement here. And there is a simple sequence of steps Circle can follow to do the enforcement. None of this makes much sense.
Circle looks to be trying to interpret things in an incredibly narrow and self-serving way to manufacture an injury Circle would suffer if it complied. And then to moan that imagined injury is unfair. If we go back to Circle's own words to the court this is clearly exactly what they are doing:
The Complaint’s sole allegation regarding Circle’s intentional disobedience is that “Circle...refused to invalidate the stolen USDC or issue new USDC,” Compl. ¶ 9. But the Complaint clearly misrepresents the content of the relevant communication. Circle did not “refuse” to invalidate the stolen USDC; it stated that it “does not hold the private keys to the address.” Compare Compl. ¶ 9 with Ex. 6. That is an accurate statement that Circle lacked the tools required to “invalidate” the USDC held in the Blocklisted Wallet, not an intentional refusal to comply with the terms of the Second Warrant.Circle was directed to "facilitate the seizure" of the funds. And then Circle asserts it did not refuse to invalidate the USDC in question – its just that Circle has no button labelled "seize" to press. But Circle did refuse to upgrade the USDC contracts to add a seize button.
Circle also presented the total non-sequitur that it "does not hold the private keys to the address" of the fraud-linked funds. This is also arguable. It is true in the sense that Circle does not hold the fraudster's private keys. But the term "private keys" is not being used in a technically precise sense here because there are two sets of private keys that can move the funds. The term "private keys" as used here connotes control over funds. And so long as Circle has the private keys to upgrade USDC it has one set of private keys that can facilitate a seizure out of the addresses in question. Remember: USDC and USDT are not true bearer assets. The issuers retain a lot of control over "your" funds.
Maybe you think we are giving the authorities too much credit and we should interpret the claim in narrow technical terms? Under that reading, you may be thinking, it is not Circle's problem the government asked for the wrong thing. We have sympathy for this sentiment. But there is a bigger problem. If we interpret everything in these documents in narrow technical terms Circle is wrong that it has "no ability to invalidate and reissue such USDC or to transfer them." It has the ability to do this by upgrading the contract to give itself the ability. This falsity then gives rise to a litany of other false claims including:
Circle "would also have to hold an additional $381,000 in US Currency to cover the new USDC": false because once Circle has burn power there is no need to double reserve. And that is if we accept the need in the first place as Circle can simply declare the address outlaw and ignore it.Circle also stated that by the terms of its own contracts, it will not “burn and reissue” USDC: this is at most a policy Circle can revise in its sole discretion. And having a policy to defy court orders is pretty much exactly what Circle is charged with here.Circle has no control of USDC held in third-party wallets: false because in a technical sense Circle has more than "no" control via contract upgradability. It has, and we apologize for the technobabble here, "some" control.Circle...has no ability to invalidate: false via upgradability.Circle...has no ability to...reissue such USDC or to transfer them: false via upgradability.If we read the claims in the dispute broadly: Circle is not being candid. If we read the claims narrowly: Circle is not being honest. Unless Circle has somehow lost the ability to upgrade USDC – which would be a far larger problem if kept hidden for so long – we just cannot see a way they are telling the truth here. Maybe there is one but there is certainly no hint of such an explanation in the court filings to date.
Circle's Principled ResistanceWhat makes this even stranger: Circle's terms also contemplate circumstances in which the company will resist court orders. But that too does not fit what is happening here. Again from the Access Denial document:
Circle reserves all rights to object to an access denial order that presents a threat to Circle Stablecoin or that Circle determines is objectionable.USDC holders do not have any rights or derive any value from this. But it presumably empowers the company to do what it is doing in Wisconsin now without worrying about shareholders suing anyone for resisting court orders. The US legal system is adversarial and Circle is 100% entitled to resist government requests and to challenge orders. Within the US system. Telling law enforcement to go pound sand after the judge rules is not something Circle is entitled to.
It is certainly possibly Circle views anything that reduce's Circle's interest income as objectionable. There is a logical, if wacky, corporate theory here: "We prefer to hold frozen assets indefinitely to maximize shareholder value. We view this as part of our fiduciary responsibility to shareholders. Victims are not shareholders sorry." Probably no company wants to come out and say that. But it is true that public companies have a responsibility to shareholders and not victims. They also have a responsibility to judges and to shareholders to not egregiously defy judges. So it is all kind of mixed together there.
Now notice the seizure warrant requests Circle is fighting here date back to August 2025. Multiple seizure warrants have been issued. And Circle has been communicating false claims to Wisconsin officials for many months now. Criminal charges were filed in April 2026. Circle moved beyond objecting to an access denial order to simply refusing to follow one after multiple rounds of back and forth. This happened over many months.
We accept it is possible to read these most recent actions as part of resisting the order. And maybe law enforcement jumped the gun with criminal charges. But it is kind of hard to credit Circle here and think ongoing negotiations without criminal charges would go anywhere. Circle has stated clearly that it cannot comply for technical reasons. Circle claims it is impossible to do what the court wants. But those claims are plainly false (or Circle is covering up something worse). For negotiations to go anywhere Circle would need to concede it was wrong or the police would need to stop asking for seizure. That looks like a stalled negotiation to us.
If Wisconsin officials were demanding Circle seize USDT then we would certainly feel for Circle. Circle is not omnipotent. There are plenty of web3 things Circle cannot do. And, obviously, it is possible for law enforcement to order someone to do something that is technically impossible for them to do. This is true of anyone and any law enforcement unit anywhere in the world. Try this one: a court could issue an order for a witness to not die before a trial. That would not have the effect of conveying immortality on the witness. Law enforcement can be wrong. But here, today, Circle is wrong.
The court wants Circle to do something that Circle can do. So we are going to make two predictions. First, Circle will eventually comply. And second, Circle will blame confusion between the legal and engineering teams for the false statements. The court should not accept that explanation. We kind of hope Circle tries the shareholder value line too. If someone says "victims are not shareholders and our fiduciary responsibility is to shareholders" that will just be too amazing for words. As odd as that outcome seems remember a listed US company is currently engaged in a dispute with law enforcement in Wisconsin in which the listed US company is just straight-up lying. This is all incredibly odd.
We have long predicted the lawyers would need to throw the engineers under the bus at some point. Honk honk.
Licensed to Shill: Retail Barely Touches Stablecoins – Treasury & Remittance Are the Real Adoption (Jeannie Lim, Xweave)
At Xweave, Jeannie Lim says her team moved $1 million for an e-commerce client in under three minutes, cutting settlement costs 30% against a Tier 2 bank’s SWIFT rate.
Lien Finance lost approximately 542,000 USDC due to a vulnerability in the bond token exchange logic. The attacker exploited this flaw to create unbacked assets and drain the protocol’s liquidity. Security researchers stated that this vulnerability allowed new tokens to be minted and exchanged for real liquidity without destroying the bond tokens.
Technical Details of the Attack Blockchain security firm SlowMist announced that the attack targeted Lien Finance’s bond exchange mechanism. The attacker used the exchangeEquivalentBonds function in the BondMakerCollateralizedEth contract to create bond tokens without destroying the input bonds and then exchanged them for USDC. This resulted in the withdrawal of approximately 542,144.63 USDC. SlowMist stated that the attack occurred because the bond groups were not sufficiently verified during the exchange. The wallet address used by the attacker was identified as 0x0d7d…1808a.
Protocol Weaknesses and Their Consequences On-chain analysis by DefimonAlerts revealed the attack occurred due to permissionless bond registration and pricing vulnerabilities. The attacker created bonds containing a malicious payment function by registering a new batch of bonds through the BondMakerCollateralizedEth contract. These bonds were routed to Lien Finance’s OTC pools and replaced with actual USDC liquidity. Following the attack, several contracts were affected, including Lien Finance’s GeneralizedDotc contract.
This incident adds another vulnerability to the recently increasing number of security breaches in DeFi protocols. In July, other protocols also suffered similar attacks, resulting in losses totaling millions of dollars. Lien Finance has not yet released a detailed technical report following this attack. Researchers note that such attacks stem from weaknesses in the protocol’s pricing and validation logic.
Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data!
Samsung just made stablecoins a default feature of its mobile wallet. At Galaxy Unpacked 2026 on July 22, the company announced that Samsung Wallet will integrate native stablecoin support, with USDC among the expected options. The move effectively puts digital dollars alongside tap-to-pay, boarding passes, and loyalty cards in the pockets of hundreds of millions of Galaxy device owners.
What Samsung actually announced The stablecoin integration was revealed as part of a broader push to make Samsung Wallet a unified hub for payments, rewards, and digital assets. Samsung framed it as a “secured payments and rewards experience.”
The company hasn’t confirmed a specific launch date for the stablecoin feature. It also hasn’t officially locked in which stablecoins will be supported beyond the strong signals pointing toward USDC, Circle’s regulated dollar-pegged token.
Advertisement
The announcement didn’t happen in isolation. Samsung simultaneously unveiled the Galaxy Card, a credit card issued by Barclays and running on the Visa network, targeting US users with tiered cash-back rewards.
In 2025, the company partnered with Coinbase to give millions of US Galaxy users access to cryptocurrency services directly through their devices. That collaboration laid the groundwork for what’s coming next, essentially graduating Samsung Wallet from a non-custodial blockchain wallet with basic crypto access into something closer to a full-featured digital asset platform.
What this means for investors For Circle, the company behind USDC, this partnership could strengthen its position ahead of any potential IPO or public market activity.
There are risks worth noting. Regulatory frameworks for stablecoins remain a work in progress in many jurisdictions. Samsung will need to navigate varying compliance requirements across its global markets, which could limit the feature’s availability to certain regions initially. The US market, where the Galaxy Card is launching alongside the Barclays partnership, is the likely first target.
The 2025 Coinbase partnership gave Samsung a foundation in crypto services, but stablecoin integration represents a fundamentally different proposition. Offering users the ability to buy Bitcoin through a partner app is one thing. Embedding dollar-equivalent digital currency into the core wallet experience is another.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.
Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.
24 July 2026 | 16:17 Samsung is preparing to bring stablecoins into Samsung Wallet, placing blockchain-based money alongside the cards, passes, IDs and digital keys already stored in the app.
Key Takeaways Samsung previewed native stablecoin functionality as part of the future direction of Samsung Wallet. The interface shown at Galaxy Unpacked displayed USDC with send, receive and top-up controls. Samsung also introduced its first credit card, issued by Barclays US Consumer Bank on the Visa network. The company has not confirmed the supported stablecoins, blockchain networks or custody model. No public stablecoin release date, eligible-device list or regional rollout has been announced. Samsung is expanding Wallet in two different directions: deeper integration with traditional finance and planned support for blockchain-based money.
During its Galaxy Unpacked presentation in London on July 22, the company previewed native stablecoin functionality inside Samsung Wallet. Alongside that roadmap, Samsung introduced its first credit card, the Samsung Galaxy Card, issued by Barclays US Consumer Bank on the Visa network and initially available in the United States.
The two announcements place both conventional credit and digital assets inside Samsung’s wider Wallet strategy, although they are at different stages. The Galaxy Card is a live financial product, while the stablecoin feature remains a future service with no announced release date.
Samsung previewed the stablecoin plan during its official Galaxy Unpacked presentation.
Samsung’s Lee Dinham described stablecoins as part of the next stage of the Wallet product:
“Samsung Wallet will expand beyond cash and savings. It will embrace new forms of digital value, including stablecoins.”
He added:
“This will make Samsung one of the first major mobile brands to bring native stablecoins to a smartphone, enabling fast and trusted digital value transfers.”
The comments establish Samsung’s intended direction, but they did not mark the launch of a usable stablecoin service. Galaxy users cannot yet activate the feature.
What Samsung Actually Showed Samsung displayed a Wallet interface containing a stablecoin account denominated in USDC. The screen included “Send,” “Receive” and “Top up” controls, indicating that the planned feature is intended to support transfers rather than simply show a balance.
The presentation did not include a completed blockchain transaction or explain how the account would be funded. Samsung did not identify whether top-ups would use a bank card, bank transfer, exchange account or another payment route.
USDC’s appearance should also be treated as part of the interface preview, not confirmation of a commercial agreement with Circle. Samsung did not name Circle, Tether or another stablecoin issuer and did not confirm which assets will be available when the service launches.
What Samsung Confirmed What Remains Unknown Stablecoin functionality is planned for Samsung Wallet. When the feature will become publicly available. USDC appeared in the interface shown at Unpacked. Whether USDC or another stablecoin will be supported at launch. The interface included send, receive and top-up controls. How users will fund, redeem or withdraw their balances. The feature will be accessible through Samsung Wallet. Supported countries, devices, networks, fees and transaction limits. Samsung Has Not Explained Who Will Control the Assets Samsung used the term “native stablecoins,” but did not provide a technical definition.
The wording indicates that stablecoin functions will be available through Samsung Wallet rather than requiring users to rely entirely on a separate crypto application. It does not establish whether the feature will be integrated more deeply into One UI or the Android operating system.
The more important unanswered question is whether users will control the cryptographic keys or whether a regulated provider will hold the assets on their behalf.
In a self-custodial system, the user controls the keys required to transfer the stablecoins. A custodial service instead places control with a bank, exchange or payments company, which manages transactions and account recovery subject to its own compliance requirements.
Samsung has technology capable of supporting self-custody. Its Blockchain Keystore can create and use private keys inside a Trusted Execution Environment isolated through Samsung Knox.
The Keystore can sign blockchain transactions without exposing the private key to ordinary Android applications or external cloud storage. Samsung has not said that this architecture will be used for the stablecoin service, so its existence should not be treated as confirmation of the final custody model.
The Galaxy Card Shows Samsung’s Broader Financial Push The Samsung Galaxy Card provides important context for the stablecoin announcement because it shows Wallet expanding through conventional finance at the same time.
The card is issued by Barclays US Consumer Bank and operates on the Visa network. Applications opened to the US public on July 22, and Samsung offers both a virtual version and a premium metal physical card.
The Galaxy Card can be added to Samsung Wallet, where it sits alongside compatible payment cards, IDs, passes and digital keys. Cardholders can earn increased cash rewards on eligible Samsung purchases, purchases made through Samsung Wallet and other qualifying spending.
The product does not use stablecoins and should not be presented as part of the future crypto service. Its significance is strategic: Samsung is making Wallet the interface through which users access an expanding set of financial products provided by Samsung and outside partners.
Samsung Wallet Already Has a Crypto Connection Samsung Wallet already combines payment and loyalty cards, identification documents, boarding passes and digital keys. It can also connect with Samsung Blockchain Wallet to help users monitor supported cryptocurrency holdings.
The stablecoin preview points toward a more active function. Instead of only displaying crypto balances, the interface suggests users could eventually add and transfer stablecoins without leaving the main Wallet application.
Samsung has also expanded crypto access through Coinbase. In October 2025, the companies announced that eligible US Coinbase customers could use Samsung Pay inside the Coinbase app, while Samsung Wallet users received promotional access to Coinbase One.
The companies said the initial partnership would reach more than 75 million Galaxy users in the United States. The arrangement connected users with Coinbase services, but it did not add Coinbase custody or trading directly to Samsung Wallet.
Samsung has not identified Coinbase as the provider behind the planned stablecoin feature.
Open USD Remains a Separate Development Open Standard lists Samsung Electronics and Samsung Card among the businesses participating in Open USD, a planned dollar-backed stablecoin.
Open Standard says participating companies will be able to issue and redeem Open USD without fees and receive a share of the revenue generated by the reserves after a management charge.
Coindoo previously examined Samsung’s involvement in the wider initiative when Open USD announced backing from more than 140 participating companies.
Neither Samsung nor Open Standard has connected Open USD to the stablecoin interface shown at Galaxy Unpacked. There is therefore no official basis for describing it as the launch asset or infrastructure behind Samsung Wallet’s planned service.
Samsung Could Make Stablecoins Feel Ordinary Most stablecoin services still require users to select an exchange or standalone wallet, create a separate account and understand blockchain networks, wallet addresses and custody arrangements.
Placing stablecoins inside Samsung Wallet could make the experience more familiar. Someone who already opens the application to use a credit card, boarding pass or digital key could access a stablecoin balance through the same interface.
The potential reach cannot yet be quantified. Samsung has not disclosed which Galaxy models or countries will receive support, and Wallet features already vary by device and market.
Stablecoins can also support programmable transfers in which software initiates payments for data or digital services. Coindoo’s analysis of how stablecoins could become a payment rail for AI agents examines that wider use case, although Samsung has not announced any connection between its Wallet roadmap and autonomous AI payments.
The impact of Samsung’s stablecoin plan will ultimately depend on the details it has not yet released: the supported assets and networks, the custody provider, funding and redemption methods, transaction costs and availability by region.
For now, Samsung has confirmed that stablecoins are part of Wallet’s future. Together with the Galaxy Card, the announcement shows the company widening Samsung Wallet from a place that stores payment credentials into a platform through which users may eventually access both conventional and blockchain-based financial services.
This article is provided for informational purposes only and does not constitute financial, investment or legal advice.
Author
Alexander Zdravkov is a market analyst and crypto journalist with interests in economics, broader financial markets and digital assets. His journey into crypto began more than four years ago, driven by a fascination with the rapid evolution of blockchain technology and the transformative potential of decentralized finance. He began analyzing market cycles and identifying emerging trends before they reach the mainstream. He holds a degree in International Relations - a background that helped shape his broader perspective on global economics, geopolitics, and the interconnected nature of modern financial markets. Whether covering the latest developments in the crypto sector or exploring broader macroeconomic themes, Alexander focuses on giving readers context rather than simply repeating headlines. During his career, he has authored more than 5,000 articles covering cryptocurrencies, traditional finance, and global market developments. His work spans everything from Bitcoin and altcoins to macroeconomic trends influencing risk assets worldwide.
Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.
Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.
Coinbase has rolled out direct USDC-BRL trading and conversion for users in Brazil, giving the country’s crypto-curious population a cleaner on-ramp between the Brazilian real and the world’s second-largest stablecoin.
The feature is live on Coinbase’s dedicated Brazilian platform at coinbase.com/en-br, where users can access real-time conversion tools, trade USDC against BRL, and, in some cases, earn yield on their holdings. Promotional rewards of up to 7% annually on USDC are part of the offering.
Why Brazil, why now USDC, issued by Circle, is pegged one-to-one to the US dollar. As of late July 2026, one USDC converts to approximately R$5.08-5.10. For Brazilian users, holding USDC is functionally like holding digital dollars, without needing a US bank account or dealing with traditional forex friction.
Coinbase launched its dedicated Brazilian platform on January 23, 2026, laying the groundwork for this kind of localized feature set. Earlier reports from 2025 had flagged limitations in BRL transaction support on the exchange, so the USDC-BRL integration represents a clear upgrade from where things stood just 18 months ago.
Advertisement
Direct fiat-to-stablecoin conversion eliminates a step that previously required users to either buy Bitcoin or Ethereum first and then swap into USDC, or use a third-party service to bridge the gap.
The stablecoin playbook in emerging markets For Coinbase specifically, Brazil represents one of only a handful of regions where the exchange has explicitly built out USDC trading and conversion infrastructure.
Brazil’s regulatory landscape passed its landmark crypto regulatory framework in 2023, and the central bank has been actively developing its own digital currency, the Drex.
The 7% annual yield promotion on USDC is worth pausing on. A dollar-denominated yield product adds a layer of currency diversification on top of the return itself, providing both yield and a hedge against real depreciation simultaneously.
What this means for investors and the competitive landscape Coinbase isn’t operating in a vacuum here. Binance, Mercado Bitcoin, and other exchanges have been aggressively courting Brazilian users for years. Binance in particular has built deep roots in the country, with BRL payment integrations and localized support that predates Coinbase’s dedicated Brazilian platform launched January 23, 2026.
Brazil’s crypto framework is still relatively young, and the central bank’s Drex project could eventually introduce a government-backed digital alternative that competes directly with private stablecoins like USDC.
The 7% promotional rate on USDC is tied to what Circle can earn on the reserves backing the stablecoin. If global interest rates decline, so do the yields that make these products compelling.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Samsung has taken a significant step in the cryptocurrency world by adding stablecoin support to its mobile wallet, Samsung Wallet. At the recent Galaxy Unpacked event, it was announced that Samsung Wallet will support stablecoins like USDC. This move brings digital dollars into the pockets of hundreds of millions of Galaxy device users.
Innovations Announced by Samsung Stablecoin integration was introduced as part of an effort to make Samsung Wallet a unified hub for payments, rewards, and digital assets. Samsung framed this innovation as a “secure payments and rewards experience.” A definitive launch date for the stablecoin feature has not yet been announced, and it hasn’t been officially confirmed which stablecoins will be supported besides USDC. However, there are strong indications that USDC will be supported.
This announcement came alongside Samsung’s introduction of the Galaxy Card, issued by Barclays and operating on the Visa network. This credit card offers various cashback rewards to US users. A partnership with Coinbase in 2025 provided millions of US Galaxy users with access to cryptocurrency services directly through their devices, laying a significant foundation for transforming Samsung Wallet into a more comprehensive digital asset platform.
What it Means for Investors For Circle, the company behind USDC, this partnership could strengthen its position ahead of a potential IPO or market activity. However, regulatory frameworks for stablecoins are still under development in many regions. Samsung will have to overcome varying compliance requirements in its global markets, which could initially lead to the feature being limited to certain regions. The Galaxy Card, in partnership with Barclays, is likely to launch in the US market as the first target.
The partnership with Coinbase in 2025 provided Samsung with a foundation in crypto services, but stablecoin integration offers an entirely different proposition. It’s one thing to offer users the ability to buy Bitcoin through a partner app, but integrating the dollar equivalent of digital currency into the core wallet experience is quite another.
Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data!
Key Takeaways VLY reported Q2 adjusted EPS of 30 cents, missing the 31-cent estimate.Valley National posts 13.3% y/y revenue growth as NII and non-interest income climb.VLY sees loan and deposit growth, but rising expenses and higher non-performing assets remain concerning. Valley National Bancorp's (VLY - Free Report)
second-quarter 2026 adjusted earnings per share of 30 cents missed the Zacks Consensus Estimate by a penny. However, the bottom line compared favorably with earnings of 23 cents in the year-ago quarter.
Results were hampered by higher non-interest expenses. Higher net interest income (NII), increased non-interest income, lower provisions for credit losses, and growth in loan and deposit balances acted as tailwinds.
Results excluded certain non-core charges. Including those, net income available to common shareholders was $163.6 million, which jumped 29.6% from the year-ago quarter.
Valley National’s Revenues Improve, Expenses RiseTotal revenues (on an FTE basis) were $562.1 million, up 13.3% year over year. The top line beat the Zacks Consensus Estimate of $552.02 million.
NII (FTE basis) was $488.4 million, up 12.6% year over year. The net interest margin (FTE basis) was 3.2%, which expanded 19 basis points (bps).
Non-interest income jumped 17.7% to $73.7 million. The rise was driven by an increase in almost all fee income components, except fees from loan servicing, net gains on sale of loans, and bank-owned life insurance.
Non-interest expenses of $311.1 million increased 9.5% year over year. The rise was due to an increase in almost all cost components, except for FDIC insurance assessment costs and amortization of other intangible assets. Additionally, no loss on extinguishment of debt was reported this quarter.
The efficiency ratio was 52.11%, down from 55.20% in the prior-year quarter. A decline in the efficiency ratio indicates an improvement in profitability.
VLY’s Loans & Deposits RiseAs of June 30, 2026, total loans were $52.5 billion, up 6.2% year over year. This increase was driven by growth across all loan categories. Total deposits were $54.1 billion, up 6.7% year over year.
Valley National’s Credit Quality: A Mixed BagAs of June 30, 2026, total non-performing assets were $467.8 million, up 6.4% year over year, primarily due to higher non-accrual loans, partially offset by other real estate owned (OREO), and other repossessed assets.
However, allowance for credit losses as a percentage of total loans was 1.16%, down 4 bps year over year. In the second quarter of 2026, VLY reported total provision for credit losses of $29.2 million, a 22.8% year-over-year decline.
VLY’s Profitability Improves, Capital Ratios MixedAt the end of the second quarter, adjusted annualized return on average assets was 1.05%, up from 0.87% in the year-earlier quarter. Adjusted annualized return on average shareholders’ equity was 8.75%, up from 7.15%.
As of June 30, 2026, the tangible common equity to tangible assets ratio was 8.71%, up from 8.63% in the corresponding period of 2025. Tier 1 risk-based capital ratio was 11.37%, down from 11.57%. Also, the common equity tier 1 capital ratio of 10.71% was down from 10.85% as of June 30, 2025.
Valley National’s Share Repurchase UpdateIn the reported quarter, VLY repurchased 1.5 million shares at an average price of $13.4 under its ongoing stock buyback program.
Our Take on VLYRobust loan growth, stabilizing funding costs, and efforts to enhance fee income are expected to keep supporting Valley National’s top-line growth. However, elevated expenses and significant exposure to commercial real estate loans remain near-term headwinds.
Valley National currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of VLY’s PeersHancock Whitney Corp.’s (HWC - Free Report) second-quarter 2026 earnings per share of $1.55 matched the Zacks Consensus Estimate. The bottom line rose 17.4% from the year-ago quarter.
HWC’s results were primarily aided by higher NII and non-interest income along with a decline in provisions. Also, a sequential increase in loans and deposit balances was positive. However, higher expenses were the undermining factor.
BankUnited, Inc.’s(BKU - Free Report) second-quarter 2026 earnings of 97 cents per share missed the Zacks Consensus Estimate of $1.02. However, the bottom line rose 6.6% from the prior-year quarter.
Results were primarily hurt by a rise in non-interest expenses. Also, sequential declines in loans and deposits were negatives. However, higher NII and fee income, along with lower provisions, provided some support to BKU’s performance.
Key Takeaways Regency Centers is expected to post higher Q2 revenues and FFO per share year over year.REG may benefit from strong leasing, resilient foot traffic and demand for grocery-anchored retail.Regency Centers maintained NOI growth guidance despite expecting softer Q2 same-property NOI growth. Regency Centers Corp. (REG - Free Report) is slated to report second-quarter 2026 results on July 29, after the closing bell. The company’s quarterly results are likely to display year-over-year growth in revenues and funds from operations (FFO) per share.
In the last reported quarter, this Jacksonville, FL-based retail real estate investment trust’s (REIT) NAREIT FFO per share of $1.20 missed the Zacks Consensus Estimate of $1.21. Results reflected a year-over-year improvement in same-property NOI driven by strong leasing.
Over the trailing four quarters, the company’s FFO per share exceeded the Zacks Consensus Estimate on two occasions and met on the other two, with the average beat being 0.69%. This is depicted in the graph below:
In this article, we will dive deep into the U.S. retail real estate market environment and the company's fundamentals and analyze the factors that may have contributed to its second-quarter 2026 performance.
US Retail Real Estate Market in Q2The second-quarter 2026 U.S. retail market showed signs of stabilization, as shopping-center demand returned to positive territory and vacancy remained near historically low levels. Limited new construction continued to support rent growth, while resilient consumer spending favored grocery, discount and other value-oriented retailers. However, uneven regional trends and rising pressure on lower- and middle-income households kept the operating backdrop mixed.
Per the Cushman & Wakefield report, net absorption reached 708,000 square feet, while national vacancy remained broadly stable at 6%, up only 3 basis points sequentially and still below the historical average of 7.4%. Limited construction continued to support market fundamentals, with just 2.3 million square feet delivered during the quarter and the development pipeline accounting for less than 0.3% of existing inventory.
Asking rents increased 2.2% year over year to $25.65 per square foot, supported by tight availability and muted new supply. The West led demand growth with 1.3 million square feet of positive absorption and was the only region to record a decline in vacancy. In contrast, the South posted a slight rise in vacancy as earlier population growth encouraged new development, creating temporary lease-up pressure in markets such as Atlanta, Houston, Washington and Dallas-Fort Worth. Even so, rents in the South advanced 3.3% year over year, the strongest growth among all regions.
Consumer spending remained resilient despite higher energy costs. Retail sales rose 6.9% year over year, or 5.4% excluding gasoline stations, while unemployment stayed low at 4.2%. However, inflation outpaced wage growth in April and May, increasing pressure on lower- and middle-income households. This widening spending divide is likely to favor grocery, discount, value and health-and-wellness retailers over discretionary categories.
Factors at Play for RegencyConsidering the above scenario, Regency Centers’ second-quarter 2026 performance is likely to have benefited from its grocery-anchored portfolio, resilient foot traffic and strong tenant demand. First-quarter foot traffic rose 2.3% and accelerated to 3% in April, while bad debt remained near record lows. Demand from grocers, restaurants, health and wellness concepts, and off-price retailers is likely to have supported occupancy, rents and leasing spreads.
Regency’s more than $600 million development and redevelopment pipeline, carrying blended returns above 9%, may have boosted total NOI growth. The company maintained full-year same-property NOI growth guidance of 3.25%-3.75% and total NOI growth above 6%, backed by project deliveries, prior acquisitions and a strong balance sheet. However, management expected second-quarter same-property NOI growth to fall below the full-year range because of a tougher expense comparison.
The Zacks Consensus Estimate for REG’s second-quarter revenues is pegged at $404.99 million, indicating a 6.3% increase from the year-ago quarter.
The company’s activities during the to-be-reported quarter were inadequate to garner analysts’ confidence. The consensus mark for quarterly FFO per share has remained unchanged at $1.20 over the past three months. The figure implies growth of 3.45% from the prior-year quarter’s reported number.
What Our Quantitative Model Predicts for RegencyOur proven model predicts a surprise in terms of FFO per share for Regency this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFO beat, which is the case here.
Regency currently carries a Zacks Rank of 3 and has an Earnings ESP of +0.68%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks That Warrant a LookHere are two other stocks from the retail REIT sector — Kimco Realty (KIM - Free Report) and Simon Property Group (SPG - Free Report) — that you may want to consider, as our model shows that these also have the right combination of elements to report a surprise this quarter.
Kimco Realty, slated to release quarterly numbers on Aug. 4, has an Earnings ESP of +0.63% and carries a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Simon Property Group, scheduled to report quarterly numbers on Aug. 10, has an Earnings ESP of +1.21% and carries a Zacks Rank of 3 at present.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
New class action for AeroVironment (AVAV) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 7/27/2026
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 27, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) securities between June 25, 2025 and June 18, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON AEROVIRONMENT, INC. (AVAV), CLICK HERE TO PARTICIPATE IN THE S.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.
That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
Our proprietary system currently recommends Valmont Industries (VMI - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
Here are three of the most important factors that make the stock of this infrastructure equipment maker a great growth pick right now.
Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Valmont is 14.7%, investors should actually focus on the projected growth. The company's EPS is expected to grow 20.3% this year, crushing the industry average, which calls for EPS growth of 10.1%.
Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.
Right now, Valmont has an S/TA ratio of 1.24, which means that the company gets $1.24 in sales for each dollar in assets. Comparing this to the industry average of 0.98, it can be said that the company is more efficient.
While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Valmont looks attractive from a sales growth perspective as well. The company's sales are expected to grow 6% this year versus the industry average of 0%.
Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for Valmont. The Zacks Consensus Estimate for the current year has surged 0.6% over the past month.
Bottom LineValmont has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that Valmont is a potential outperformer and a solid choice for growth investors.
Sensient Technologies NYSE: SXT reported second-quarter 2026 results marked by double-digit local-currency growth in revenue, adjusted EBITDA and adjusted earnings per share, as demand for natural color conversions continued to build ahead of U.S. regulatory deadlines.
Chairman, President and Chief Executive Officer Paul Manning said the company delivered 10% local-currency revenue growth, 21% local-currency adjusted EBITDA growth and 26% local-currency adjusted EPS growth during the quarter. He said the performance exceeded the company’s earlier expectations for the year and supported an increase in its full-year outlook.
Get Sensient Technologies alerts:
Revenue rose to $462.1 million from $414.2 million in the prior-year quarter, while operating income increased to $76.7 million from $57.7 million, according to Vice President and CFO Tobin Tornehl. The prior-year operating income figure included $3.3 million of costs tied to the company’s Portfolio Optimization Plan.
Color Group Leads Growth The Color Group was the company’s strongest-performing segment, posting 17.6% local-currency revenue growth and 36.8% local-currency operating-profit growth. Its adjusted EBITDA margin reached 28.3%, up 320 basis points from a year earlier.
That margin included about $4.3 million of one-time tariff refunds, which added 200 basis points to the segment’s adjusted EBITDA margin. Excluding the refunds, the Color Group’s adjusted EBITDA margin would have been 26.3%, Manning said.
The company invoiced approximately $25 million in natural color conversion revenue during the second quarter, in addition to the $20 million cumulatively invoiced through the end of the first quarter. Manning said those invoiced amounts represent orders already billed rather than projections of future sales.
During the question-and-answer session, Manning said $25 million in invoiced quarterly sales would typically correspond to at least $100 million in projected annual revenue under normal ordering patterns. He said natural-color conversions can make the relationship less direct because customers may transition existing shelf inventory from synthetically colored products to natural alternatives over time.
Manning said customers generally aim to maintain the appearance of products when moving from synthetic to natural colors. He said color remains important to consumer expectations around a product’s flavor and overall appeal, while advances in natural-color technologies have helped customers achieve close matches in a broad range of applications.
He added that Sensient’s Flavors & Extracts business supports the conversion work through taste-masking platforms designed to address potential off-notes from natural colors.
The company expects the Color Group to generate local-currency revenue growth in the high teens for full-year 2026. Manning said third-quarter EBITDA margins in the segment are expected to be similar to the prior year’s third-quarter margin of 24.7%, while Tornehl said the company expects Color Group margins to be in the mid-20% range for the full year.
Other Segments Post Gains The Flavors & Extracts Group recorded 3.8% local-currency revenue growth and 6.1% local-currency operating-profit growth. Its adjusted EBITDA margin rose 30 basis points to 18.1%. Manning cited volume growth in agricultural ingredients, as well as continued cost optimization and new flavor wins. Sensient expects mid-single-digit local-currency revenue growth for the group in 2026.
The Asia Pacific Group reported 12.3% local-currency revenue growth and 23.7% local-currency operating-profit growth. Adjusted EBITDA margin increased 210 basis points to 24.4%. The company said the segment’s first-half performance was faster than anticipated and expects high-single-digit revenue growth for the full year.
Tornehl said the company received roughly $5 million of tariff refunds during the quarter, most of which benefited the Color Group. The refunds contributed approximately $0.09 to earnings per share, and Sensient does not expect additional refunds of significance in future periods. Foreign-currency translation increased EPS by about $0.02 during the quarter.
Guidance Raised and Investment Continues Based on its first-half performance, Sensient raised its 2026 outlook. The company now expects local-currency revenue growth of high single digits to low double digits and local-currency adjusted EBITDA and EPS growth in the mid- to high-teens range. Its prior outlook had called for high-single-digit to double-digit growth in adjusted EBITDA and EPS.
The company plans to continue investing to support natural color conversion demand. Sensient expects 2026 capital expenditures of $150 million to $170 million, trending toward the upper end of that range, and continues to anticipate spending about $250 million on natural-color capital projects over the next several years.
Cash flow from operations was $48 million in the second quarter, while capital expenditures totaled $39 million. Net debt to credit-adjusted EBITDA stood at 2.3 times as of June 30. Tornehl said the ratio is expected to reach the mid- to upper-2-times range later in the year as the company increases inventory investments to support conversion revenue.
Manning said Sensient will evaluate acquisition opportunities but does not anticipate share repurchases in the near term. He said the company’s supply-chain investments, production capacity additions and product-development work are intended to support its goal of reaching $1 billion in natural color sales.
The U.S. ban on Red 3 takes effect in January 2027 for food, beverage and pet products, with pharmaceutical products facing a January 2028 date. Mexico has also announced a ban on Red 3, with brands required to replace it by mid-2028. Manning said conversion demand is building as customers work toward product-launch and compliance timelines.
About Sensient Technologies (NYSE:SXT)Sensient Technologies Corporation is a global leader in the manufacture and supply of colors, flavors and fragrances for a broad range of end-markets. The company develops and produces ingredients that enhance the appearance, taste and scent of products in the food, beverage, nutraceutical, pharmaceutical, personal care and household sectors. Its portfolio includes natural and synthetic colorants, botanical and artificial flavor systems, fragrance compounds and specialty chemical offerings tailored to customer specifications.
Within its flavor and fragrance division, Sensient provides custom formulations for sweet, savory and umami taste profiles along with fragrance blends for personal care and cosmetic applications.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Sensient Technologies Right Now?Before you consider Sensient Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sensient Technologies wasn't on the list.
While Sensient Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Resideo Technologies (REZI - Free Report) , which belongs to the Zacks Security and Safety Services industry.
When looking at the last two reports, this residential comfort and security systems maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.47%, on average, in the last two quarters.
For the most recent quarter, Resideo Technologies was expected to post earnings of $0.61 per share, but it reported $0.65 per share instead, representing a surprise of 6.56%. For the previous quarter, the consensus estimate was $0.47 per share, while it actually produced $0.5 per share, a surprise of 6.38%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Resideo Technologies. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Resideo Technologies has an Earnings ESP of +0.24% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on August 12, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Hayward Holdings delivered impressive Q1 FY26 results, with revenue up 11.5% and profitability sharply higher. Most revenue growth in North America stemmed from price increases (10.3%), with segment profits rising 16.1% on pricing and operational efficiencies. Despite strong fundamentals and resilient aftermarket exposure, HAYW shares now appear fairly valued or even pricey versus peers.
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
Based in Des Moines, Principal Financial (PFG - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 21.66%. The financial services company is paying out a dividend of $0.82 per share at the moment, with a dividend yield of 3.06% compared to the Insurance - Multi line industry's yield of 1.79% and the S&P 500's yield of 1.33%.
Looking at dividend growth, the company's current annualized dividend of $3.28 is up 6.5% from last year. Over the last 5 years, Principal Financial has increased its dividend 4 times on a year-over-year basis for an average annual increase of 5.97%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Principal Financial's current payout ratio is 38%, meaning it paid out 38% of its trailing 12-month EPS as dividend.
PFG is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $9.45 per share, representing a year-over-year earnings growth rate of 14.27%.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. But, not every company offers a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, PFG is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against BitGo Holdings, Inc. ("BitGo" or the "Company") (NYSE: BTGO) on behalf of all persons or entities who purchased or acquired: (a) BitGo Class A common stock in and/or traceable to BitGo's January 22, 2026 initial public offering ("IPO"); and/or (b) BitGo securities between January 22, 2026 and May 13, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in BitGo and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 7, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
On or around January 22, 2026, BitGo conducted its IPO, selling 11,821,595 shares of Class A common stock at the offering price of $18 per share.
On March 26, 2026, BitGo issued a press release announcing its fourth quarter and full year 2025 financial results. The Company reported a net loss of $14.8 million for 2025, compared to $156.6 million in net income for 2024, a quarterly margin of 0.21% in its Digital Asset Sales segment, compared to a quarterly margin of 0.47% in the prior year. BitGo stated that the change in its annual net loss was "materially driven by declines in digital asset prices impacting the Company's Bitcoin treasury."
Following this news, the price of BitGo stock fell $1.43 per share, over 15.71%, to close at $7.67 per share on March 27, 2026.
Then, on May 13, 2026, BitGo issued a press release announcing its first quarter 2026 financial results. The Company reported a net loss of $60.7 million, compared to a net loss of $25.7 million in the same quarter one year earlier, stating that its quarterly net loss "was primarily driven by non-cash mark-to-market impacts related to the Company's Bitcoin treasury, as well as elevated IPO-related stock-based compensation expense.".
Following this news, the price of BitGo stock fell $2.05 per share, over 17.2%, to close at $9.86 per share on May 14, 2026.
The complaint alleges, among other things, that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that (i) Defendants understated the scope and severity of the risk that declining digital asset prices posed to Company's business and financial performance; (ii) consequently, Defendants' statements regarding, inter alia, BitGo's financial performance and business prospects lacked a reasonable basis; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed to state information required to be stated therein.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc ("EquipmentShare" or the "Company") (NASDAQ: EQPT) on behalf of investors who purchased or otherwise acquired EquipmentShare common stock pursuant and/or traceable to the Company's initial public offering on or around January 23, 2026 (the "IPO"), or between January 23, 2026 and June 23, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in EquipmentShare and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than September 21, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
According to the complaint, in the IPO, the Company sold 30.5 million shares of Class A common stock at a price of $24.50 per share. Then, on June 24, 2026, according to the complaint, "Umibōzu Research, a stock market focused media outlet, published a report alleging, among other things, that 'undisclosed related party transactions . . . have netted' entities affiliated with EquipmentShare founders 'at least $77 million, with the true figure potentially running substantially higher.'" According to the complaint, on this news EquipmentShare's stock price fell $1.58, or 6.62%, to close at $22.30 on June 24, 2026, and declined $2.61, or 11.7%, the next trading day to close at $19.69 per share on June 25, 2026.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Verra Mobility Corporation ("Verra Mobility" or the "Company") (NASDAQ: VRRM) on behalf of investors that purchased or otherwise acquired Verra Mobility common stock between February 24, 2026 and May 26, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Verra Mobility and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 4, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
On May 26, 2026, Verra Mobility issued a press release disclosing that the Company had received a termination notice from Avis Budget Group regarding its contract, which becomes effective in September 2026. Verra Mobility further disclosed that it "expects the termination to reduce Commercial Services' 2026 annualized revenue by approximately $135 million to $145 million and 2026 annualized segment profit by approximately $120 million to $125 million, before taking into account expected cost reduction initiatives." Verra also lowered its full year 2026 financial outlook.
Following this news, Verra Mobility's stock price fell $9.23 per share, or 70.6%, to close at $3.85 per share on May 27, 2026.
The complaint alleges that throughout the Class Period, Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Verra Mobility's relationship with Avis Budget Group.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Verra Mobility Corporation (NASDAQ: VRRM).
Key Takeaways Axon Enterprise is growing across devices and software but faces higher costs, debt and a richer valuation.Woodward expects strong fiscal 2026 sales growth, backed by aerospace demand and industrial strength.WWD combines lower valuation, shareholder returns and growth prospects, making it the stronger pick. Axon Enterprise, Inc. (AXON - Free Report) and Woodward, Inc. (WWD - Free Report) are two familiar names operating in the aerospace and defense equipment industry. As rivals, these companies are engaged in producing highly engineered public security and defense solutions in the United States and internationally.
Both companies have been enjoying significant growth opportunities in the public safety and defense industries on account of growing instances of terrorism and criminal activities and the expansionary U.S. budgetary policy. Let’s take a closer look at their fundamentals, growth prospects and challenges.
The Case for AxonAxon’s Connected Devices segment is thriving on the back of strong demand for TASER devices. Solid demand for virtual reality training services, TASER 10 handle and counter-drone equipment also supports the segment’s growth. Segmental revenues surged 33% year over year in the first quarter of 2026, following an increase of 29.1% in 2025.
The company continues to witness growing popularity for its next-generation TASER 10 products, whose shipment began in 2023. Growth in cartridge revenues, driven by higher adoption of the TASER products, has been driving the segment’s performance.
An increase in the aggregate number of users to the Axon network is aiding the Software & Services segment. After witnessing a year-over-year 39.6% jump in revenues in 2025, revenues from the segment increased 35% in first-quarter 2026. Continued momentum in digital evidence management and increased adoption of its latest software offerings are driving the segment’s growth.
The company is strengthening its foothold in the counter-drone space with the growing capabilities of its Dedrone offerings and Artificial Intelligence (AI)-powered command-and-control platform. It recently launched Dedrone C2, an upgraded version of the Dedrone platform. This C2 version comes with enhanced sensor fusion technology, offering stronger detection capabilities.
AXON has also been focusing on strategic collaborations with other companies to expand its counter-drone capabilities and customer base. Last year, Axon entered into a partnership with TYTAN (a leading provider of interceptor systems for Group 3 drones) to boost detection, identification and mitigation capabilities of counter-drone equipment.
On the flip side, escalating costs and expenses are a concern for Axon’s bottom line. In the first three months of 2026, its cost of sales and SG&A expenses increased 38.8% and 15.9%, respectively, year over year. Total operating expenses climbed 19.6% year over year to $448 million. The company incurred high costs and expenses related to business integration activities and stock-based compensation expenses.
Axon has been facing the pressure of rising debt levels. Exiting the first quarter of 2026, the company’s long-term notes payable (net) were $1.73 billion. This increase was primarily due to funds raised to support the company’s strategic investments, expansion activities and potential acquisitions. Considering its high debt level, its cash and cash equivalents of $458.9 billion do not look impressive.
The Case for WoodwardWoodward’s Aerospace business is gaining momentum with strength in the commercial aftermarket as well as higher defense activity, despite supply-chain challenges. In the second quarter of fiscal 2026 (ended March 2026), net sales for the segment were up 25% year over year, driven by broad-based strength across commercial services and defense OEM. Driven by strength across its business, Woodward projects its Aerospace segment to grow 21–24% in fiscal 2026 (ending September 2026), up from the earlier estimated 15–20% range.
The company’s Industrial business segment continues to benefit from solid demand for power generation equipment and services, along with favorable conditions in marine transportation and steady investment in parts of oil and gas. In the fiscal second quarter, Industrial sales increased 20% year over year, with Core Industrial sales up 19% excluding China on-highway. For fiscal 2026, Woodward expects consolidated net sales to rise 20-23%, with the Industrial segment anticipated to increase 18-20%.
The company’s disciplined capital deployment remains focused on organic growth, returning cash to shareholders and pursuing strategic acquisitions. As part of this strategy, the company is making a multiyear investment in a new state-of-the-art facility to support the Airbus A350 spoiler actuation program and long-term organic growth. Also, it closed the acquisition of Valve Research & Manufacturing in March 2026. The buyout will complement Woodward’s engineering, design and manufacturing capabilities in fuel and motion control systems.
During the first six months of fiscal 2026, the company returned $391.1 million to its shareholders in the form of $35.8 million of dividends and $355.3 million of share repurchases. Also, in November 2025, WWD’s board approved a new $1.8 billion share repurchase authorization over three years, underscoring confidence in the company’s strong balance sheet and long-term growth outlook.
Its healthy liquidity position adds to its strength. Management continues to guide $300-$350 million of free cash flow for fiscal 2026 and about $290 million of capital expenditures, and highlighted inventory initiatives are intended to improve cash generation in fiscal 2027.
Price Performance
Image Source: Zacks Investment Research
In the past six months, Axon shares have lost 18.7%, while Woodward stock has gained 24.4%.
The Zacks Consensus Estimate for AXON & WWDThe Zacks Consensus Estimate for AXON’s 2026 sales and earnings per share (EPS) implies year-over-year growth of 31.5% and 14.3%, respectively. The EPS estimates for both 2026 and 2027 have been stable over the past 60 days.
Image Source: Zacks Investment Research
The consensus estimate for WWD’s fiscal 2026 sales implies growth of 21.2% year over year, while the EPS estimate implies a 35.6% increase. WWD’s EPS estimates for fiscal 2026 and 2027 (ending September 2027) have remained unchanged over the past 60 days.
Image Source: Zacks Investment Research
Woodward’s Valuation Attractive Than AxonWoodward is trading at a forward 12-month price-to-earnings ratio of 40.15X, while Axon’s forward earnings multiple sits much higher at 52.27X.
Image Source: Zacks Investment Research
ConclusionAxon’s strong momentum across operational segments and growing presence in the counter-drone space have been dented by rising expenses and a high debt level, which might affect its margins and performance. Also, AXON’s expensive valuation warrants a cautious approach for existing investors.
In contrast, Woodward’s market leadership position and strength in aerospace and industrial businesses provide it with a competitive advantage to leverage the long-term demand prospects in the market. WWD holds robust prospects due to strong estimates, stock price appreciation, attractive valuation and solid prospects for sales and profit growth.
Given these factors, WWD seems to be a better pick for investors than AXON currently. While WWD currently carries a Zacks Rank #2 (Buy), AXON has a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
All REP holders must migrate their tokens by August 1, 2026, to remain part of the active Augur ecosystem Augur, one of Ethereum’s earliest decentralized prediction-market and oracle projects, today announced that the second and final phase of its Moon Fork is entering its final days, with the two-month migration window for all holders of its REP token closing on August 1.
REP holders must migrate their tokens 1:1 into an outcome-specific version of REP by August 1, 2026. Migration is one-way and irreversible. Tokens that remain in the legacy Augur universe after the window closes will no longer be able to follow the active protocol and are likely to lose their economic value. After that point, unmigrated REP can no longer be converted.
Migration tooling is available through Augur’s official fork interface at 6.augurfork.eth.limo, together with a step-by-step guide and frequently asked questions.
The fork is a live demonstration of how a decentralized system can defend a truthful outcome without any central authority ruling on the result. That security depends on participation: REP only protects the protocol when its holders act.
A live test of Augur’s economic security model The Moon Fork began on April 8 with an intentionally escalated dispute over the question: Did the Artemis II mission successfully lift off in the first week of April?
The dispute was initiated by longtime Augur community member Micah Zoltu to test the protocol’s full resolution process under real economic conditions. The correct outcome was “Yes.”
The process was designed to test the mechanism from beginning to end, including participant incentives, capital formation, dispute escalation and token migration. Augur entered the fork after enough REP was committed across successive dispute rounds to activate the protocol’s final resolution backstop.
The fork consists of two phases.
Phase one: The escalation game From April through early June, REP holders could stake on competing answers through a series of increasingly expensive dispute rounds.
Each round required more capital than the one before it. Participants staking on the ultimately accepted outcome were eligible to earn a return funded by the losing side, creating a financial incentive for the wider market to oppose manipulation.
“Most people will interact with Augur during the escalation game, which lets outcomes battle it out by seeing who can raise more money. The losers pay out the winners. Since it’s easier to raise money on an outcome people believe to be true, that’s the one with the advantage. So in this phase we try to outspend the attacker, and if we can’t, we go to phase two,” said Phill Monastirsky, co-founder of the Lituus Foundation, which stewards Augur.
The escalation process continued until the dispute reached Augur’s fork threshold. Phase one is now complete.
Phase two: Mandatory REP migration The protocol has now split into separate outcome-specific universes. Every REP holder must choose a universe and migrate their REP into the corresponding token.
“Failing to outspend the attacker, we now try to maximize their cost by forcing them into a worthless token,” said Phill. “The protocol splits into tokens corresponding to the possible outcomes, with 51% required to win. Since future Augur fees only continue on the truthful token, the attacker is forced to move 51% of the token supply into something worthless. In the Augur Lituus design, this rises to near 100%. As long as it costs them more to do that than they gain from misresolving the market, we are safe.”
Future official Augur development funded by the Lituus Foundation will continue on the universe corresponding with the truthful outcome: that Artemis II successfully lifted off during the period specified by the market.
The Foundation has migrated its own holdings and added liquidity to the corresponding token.
What REP holders need to do REP holders should take the following steps before August 1:
Hold REP in a self-custodied Ethereum wallet or confirm that their exchange will support the migration Visit 6.augurfork.eth.limo/#/migration Connect the wallet holding REP Migrate REP 1:1 into the outcome-specific token corresponding with the truthful result Confirm receipt of the new REP token in the connected wallet Migration cannot be reversed once completed.
REP held on centralized exchanges may require action by the exchange rather than the individual user. The Lituus Foundation has been working with exchanges to support migration on behalf of their users. Kraken has confirmed support; other exchanges have not, and holders should not assume support unless their exchange states it explicitly. Current exchange-support status is maintained at v3.augur.net/#exchange-support.
Exchange support may change during the migration period. Holders who cannot confirm support should withdraw their REP to a self-custodied wallet and complete the migration directly.
Why the fork matters Prediction-market platforms ultimately depend on a resolution process to determine which outcome occurred and where funds should be paid.
Many systems rely on companies, committees, token votes, multisigs or discretionary intervention. Augur was designed around a different model: an open economic process in which participants can challenge an outcome and are financially rewarded for defending the result the broader market recognizes as true.
When a dispute reaches the fork stage, REP separates into tokens associated with each possible outcome. Holders decide which universe will carry the protocol’s future economic activity by migrating into it.
The design shifts the security question away from whether a sufficiently wealthy attacker can temporarily influence a vote. Instead, it asks whether an attacker is willing to acquire and sacrifice enough REP to support a false universe that users, developers and liquidity providers may subsequently abandon.
Demonstrating the mechanism behind Augur’s next chapter The Moon Fork is testing Augur v2’s dispute architecture. Future implementations will differ from the original system, but the live exercise demonstrates the escalation-and-fork pattern underpinning Augur’s continuing oracle research.
That work includes Augur Lituus, a proposed modular resolution layer designed to allow prediction markets and other applications to outsource disputed real-world outcomes to an open, economically secured oracle.
The Lituus Foundation is funding continued work on Augur’s decentralized resolution infrastructure. The prediction-market platform under development through the separate Dark Florist workstream is expected to support the branches created through the fork, rather than the legacy unmigrated REP token.
The live migration provides a practical demonstration of Augur’s core thesis: a prediction market should not depend on any single party having the authority to declare what happened.
Important migration information Migration deadline: August 1, 2026
Migration ratio: 1:1
Migration status: Mandatory for holders who want to remain part of the active Augur ecosystem
Migration direction: One-way and irreversible
Migration portal: 6.augurfork.eth.limo/#/migration
Holders should consult the official migration interface and Augur channels for the latest technical instructions and exchange-support updates.
About Augur Augur is a decentralized prediction-market and oracle project originally built on Ethereum. Its dispute system uses open participation and economic incentives, with algorithmic forking as a final backstop, to resolve contested real-world outcomes.
About the Lituus Foundation The Lituus Foundation stewards the revival and continued development of Augur. The Foundation supports open-source development carrying Augur’s oracle research and engineering forward.
Disclaimer: TheNewsCrypto does not endorse any content on this page. The content depicted in this Press Release does not represent any investment advice. TheNewsCrypto recommends our readers to make decisions based on their own research. TheNewsCrypto is not accountable for any damage or loss related to content, products, or services stated in this Press Release.
Key Takeaways SIGI beat Q2 earnings as stronger underwriting and investment income offset lower premiums written. SIGI improved its combined ratio to 98% and raised its 2026 after-tax net investment income outlook. SIGI repurchased shares and posted its eighth straight quarter of double-digit operating returns. Selective Insurance Group, Inc. (SIGI - Free Report) reported second-quarter 2026 operating earnings of $1.95 per share, which beat the Zacks Consensus Estimate by 13.4%. The bottom line increased 48.9% year over year.
Revenues of $1.37 billion rose 4.5% from the year-ago quarter and topped the consensus estimate by 0.7%. Results benefited from stronger investment income and improved underwriting, while lower premiums written reflected continued portfolio actions.
SIGI's Underwriting Results ImproveNet premiums written declined 5% year over year to $1.22 billion due to a 6% decrease in Standard Commercial Lines, an 8% fall in Standard Personal Lines, and a 2% decline in Excess and Surplus Lines. Our estimate was $1.33 billion.
Net premiums earned increased 2.3%. Direct new business fell to $206.1 million from $248.1 million. Renewal pure price increases averaged 6.5%, down from 9.9% in the prior-year quarter.
The combined ratio improved 220 basis points to 98%. Lower catastrophe and non-catastrophe property losses, along with no prior-year casualty reserve development, supported the improvement. Higher current-year casualty loss costs partly offset these benefits.
SIGI's Investment Income Adds SupportAfter-tax net investment income increased 18% year over year to $119.2 million. Net investment income per common share rose 20% to $1.98.
The after-tax yield was 4.4% for fixed-income securities and 4.2% for the overall portfolio. Investment income contributed 13.9 percentage points to annualized return on equity, up from 13 points a year ago.
SIGI's Commercial Lines Performance StrengthensStandard Commercial Lines net premiums written fell 6% year over year to $961.9 million as lower new business weighed on production. Our estimate was $1 billion.
Net premiums earned rose 3% to $962 million, while retention was 81%.
The segment's combined ratio improved 350 basis points to 99.3%. The improvement reflected no prior-year casualty reserve development and lower non-catastrophe property losses, partly offset by higher current-year casualty loss costs.
SIGI's Personal Lines Margin NarrowsStandard Personal Lines net premiums written declined 8% to $101.5 million, while net premiums earned decreased 5% to $97.6 million. Our estimate for net premiums written was $111.4 million. New business fell 36%, renewal pure price increased 8.9% and retention remained at 79%.
The segment's combined ratio deteriorated 390 basis points to 95.5%. Higher non-catastrophe property losses and a higher expense ratio pressured the result, though lower catastrophe losses provided some relief.
SIGI's Excess and Surplus Results Stay ProfitableExcess and Surplus Lines net premiums written decreased 2% year over year to $157.3 million. Our estimate was $174.7 million. Net premiums earned increased 5% to $155.8 million, while average renewal pure price rose 3.4%.
The segment's combined ratio increased 200 basis points to 91.8%. Higher current-year casualty loss costs and non-catastrophe property losses more than offset lower catastrophe losses.
SIGI's Profitability and Capital ImproveAfter-tax underwriting income was $19.3 million against a loss of $1.9 million a year earlier. Non-GAAP operating income climbed 46% to $117.6 million, while net income available to common stockholders increased 52% to $127.1 million.
Operating return on common equity improved 340 basis points year over year to 13.7%. The company marked its eighth consecutive quarter of double-digit operating returns.
Total expenses increased slightly to $1.22 billion from $1.21 billion, reflecting higher other insurance expenses. Our estimate was $1.24 billion.
SIGI's Balance Sheet Gains GroundSelective Insurance ended the quarter with total assets of $15.62 billion, up 3% from year-end 2025. Total investments increased 2% to $11.58 billion, while common stockholders' equity rose 2% to $3.46 billion.
Book value per common share was $58.13, up 3% sequentially, while adjusted book value per share increased 3% to $60.56. During the quarter, the company repurchased $32 million of shares at an average price of $84.72.
Selective Insurance Raises Investment Income OutlookFor 2026, Selective Insurance continues to expect a GAAP combined ratio of 96.5-97.5, including 6 points of catastrophe losses. The outlook assumes no prior-year casualty reserve development.
The company raised its after-tax net investment income guidance to $480 million from $465 million. It continues to project an effective tax rate of 21.5% and now expects weighted average diluted shares of 60.2 million.
Zacks RankSelective Insurance currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Property and Casualty InsurersChubb Limited (CB - Free Report) reported second-quarter 2026 core operating earnings of $7.26 per share, which beat the Zacks Consensus Estimate of $6.63 by 9.5%. The bottom line increased 18.2% year over year. Revenues rose 2.7% year over year to $15.77 billion but missed the consensus mark of $15.90 billion by 0.8%.
Stronger P&C underwriting, record investment income, and higher life insurance income supported results. Net premiums earned increased 5.8% to $13.89 billion. P&C underwriting income increased 18.8% year over year to $1.94 billion. The combined ratio improved 180 basis points to 83.8%, reflecting a lower share of premiums consumed by claims and expenses. Our estimate was $1.15 billion.
The Travelers Companies, Inc. (TRV - Free Report) reported second-quarter 2026 core income of $10.04 per share, which beat the Zacks Consensus Estimate of $5.21 by 92.7%. The bottom line climbed 54% year over year. Revenues of $12.09 billion missed the Zacks Consensus Estimate of $12.27 billion by 1.5%.
Net investment income rose 14% year over year to $1.07 billion pre-tax ($883 million after tax). The combined ratio improved 670 basis points year over year to 83.6%, reflecting lower catastrophe losses, stronger reserve development and a better underlying combined ratio.
W.R. Berkley Corporation (WRB - Free Report) reported second-quarter 2026 operating income of $1.27 per share, which beat the Zacks Consensus Estimate by 16.5%. The bottom line increased 21% year over year. W.R. Berkley’s net premiums written were about $3.4 billion, up 2.4% year over year. The figure surpassed our estimate of $3.4 billion.
Operating revenues totaled $ 3.8 billion, up 3.6% year over year. The top line surpassed the consensus estimate by 1.87%. Net investment income grew 10.4% to $418.7 million, supported by higher invested assets and higher portfolio yields. The figure topped our estimate of $407 million. The consensus estimate was $395.6 million.
Key Takeaways Baxter is set to report Q2 results with revenues and EPS expected to decline year over year.BAX faces pressure from manufacturing inefficiencies, inflation, and Novum pump shipment hold.BAX sees mixed segment trends, with Advanced Surgery strength offset by infusion and pharma weakness. Baxter International Inc. (BAX - Free Report) is scheduled to release second-quarter 2026 results on July 30, before the opening bell. In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 16.13%. BAX’s earnings beat estimates in two of the trailing four quarters and missed twice, delivering an average surprise of 3.12%.
BAX’s Q2 EstimatesThe consensus estimate for revenues is pegged at $2.84 billion, indicating a decline of 0.6% from the prior-year quarter’s reported figure. The consensus mark for earnings is pinned at 36 cents per share, implying a 39% year-over-year decline.
Our model estimates total revenues from continuing operations to decline 2.5% at constant currency (cc) to $2.79 billion. Adjusted earnings per share are expected to decline 39% to 36 cents.
Important Factors to Note Ahead of BAX’s Q2 ResultsBaxter is expected to have delivered a modestly improved second quarter, though results are likely to be constrained by ongoing manufacturing inefficiencies, inflationary cost pressures and the continued shipment hold on its Novum large-volume infusion pump (LVP). Management reiterated its full-year outlook following first-quarter results, indicating that second-quarter earnings may remain on par with the first quarter, with only a slight volume improvement before a more meaningful recovery in the second half.
While end-market demand remains healthy across several businesses, execution-related challenges and difficult year-over-year comparisons are expected to have weighed on profitability.
Within the Medical Products & Therapies (“MPT”) segment, performance is likely to have remained mixed. Advanced Surgery should have continued to outperform, supported by strong global demand for hemostats and sealants along with healthy procedural volumes. However, Infusion Therapies & Technologies is likely to have remained under pressure due to the ongoing Novum LVP shipment and installation hold, lower infusion pump sales and normalization in IV solutions demand following last year's Hurricane Helene-related distributor build.
Management expects pump revenues to improve during the second half as Spectrum adoption increases, but elevated manufacturing absorption costs should have constrained its second-quarter performance. Our model estimates this segment’s revenues to decline 3% at cc to $1.3 billion.
Healthcare Systems & Technologies is expected to post another subdued quarter, with stronger Patient Support Systems demand and a healthy U.S. capital equipment order book partially offset by timing delays in Front Line Care installations. Management continues to expect improvement later in the year as recently launched products, including Connex 360 and the Dynamo smart stretcher, begin contributing more meaningfully. Our model estimates this segment’s revenues to improve 2.9% at cc to $795.1 million.
The Pharmaceuticals segment likely remained challenged by supply constraints within Injectables, softer global demand for inhaled anesthesia products and unfavorable product mix. Nevertheless, improving manufacturing throughput, continued progress clearing back orders and strong growth in drug compounding should have partially mitigated these headwinds. Our model estimates this segment’s revenues to decline 3.6% at cc to $609 million.
Baxter likely continued to face elevated manufacturing costs, tariff-related expenses and inflationary pressures during the second quarter. Management expects these pressures to ease during the second half as higher-cost inventory is worked through, cost-reduction initiatives begin generating savings and operating leverage improves with seasonal volume recovery. Consequently, second-quarter adjusted EPS is likely to have remained near first-quarter levels.
What the Zacks Model Unveils for BAX StockOur proven model does not conclusively predict an earnings beat for Baxter this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here, as you will see below.
BAX’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is -0.99% for Baxter. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank of BAX: Baxter currently has a Zacks Rank #4 (Sell).
BAX’s Share Price PerformanceSo far this year, Baxter’s shares have gained 13.4% against the industry’s 22.5% decline. The S&P 500 has gained 9.3% during the period.
Image Source: Zacks Investment Research
Stocks Worth a LookHere are some stocks from broader medical sector worth considering, as these have the right combination of elements to post an earnings beat this reporting cycle.
Cardinal Health (CAH - Free Report) has an Earnings ESP of +1.24% and a Zacks Rank #2 at present. The company is set to release fourth-quarter fiscal 2026 results on Aug. 11. You can see the complete list of today’s Zacks #1 Rank stocks here.
CAH’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 10.27%. The Zacks Consensus Estimate for CAH’s fourth-quarter EPS indicates an improvement of 16.4% from the year-ago reported figure.
Henry Schein (HSIC - Free Report) has an Earnings ESP of +0.41% and a Zacks Rank of 2 at present. The company is scheduled to release second-quarter 2026 results on Aug. 04.
HSIC’s earnings surpassed estimates in three of the trailing four quarters and missed once, with the average surprise being 3.74%. The Zacks Consensus Estimate for HSIC’s second-quarter EPS implies an improvement of 10.9% from the year-ago reported figure.
Agilent Technologies (A - Free Report) has an Earnings ESP of +1.02% and a Zacks Rank of 3 at present.
A’s earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 1.61%. The Zacks Consensus Estimate for A’s third-quarter fiscal 2026 EPS suggests an improvement of 8% from the year-ago reported figure.
Key Takeaways Cencora is positioned for growth on U.S. healthcare strength, specialty expansion and product launches.COR is integrating OneOncology and RCA to build a scalable specialty care ecosystem across key therapies.Cencora faces pricing headwinds, higher interest expense and regulatory risks despite logistics gains. Cencora (COR - Free Report) is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.
This Zacks Rank #2 (Buy) company’s shares have lost 9.7% in the year-to-date period compared with the industry’s 1.8% drop. However, the S&P 500 Index has gained 7.4% in the same time frame.
Cencora is one of the world’s largest pharmaceutical service companies. It is focused on providing drug distribution and related services to reduce healthcare costs and improve patient outcomes. The company has a market capitalization of $58.48 billion.
COR’s bottom line is anticipated to improve 10.1% over the next five years. Its earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 1.6%.
Image Source: Zacks Investment Research
Let’s delve deeper.
Positive Factors Driving COR’s ProspectsSpecialty Expansion and MSO Strategy Support Long-Term Growth: Cencora continues to strengthen its position in specialty pharmaceuticals, a market expected to account for more than half of U.S. drug spending in the coming years. During the second-quarter earnings call, management highlighted progress in integrating OneOncology, acquired in February 2026, with Retina Consultants of America (RCA). Management is leveraging both platforms by sharing capabilities in clinical research, trial support and back-office services, creating a scalable specialty care ecosystem. These investments complement Cencora's broader strategy of deepening manufacturer partnerships while expanding services to community providers, positioning the company to benefit from growing demand for oncology, retina and other specialty therapies.
Pharmaceutical Supply Chain Leadership and Expanding Market Opportunity: Cencora's pharmaceutical-centric strategy remains a competitive advantage. The company continues investing in automated fulfillment centers, digital infrastructure and AI-supported tools that improve inventory management, customer visibility and operational efficiency across the pharmaceutical supply chain. These capabilities reinforce Cencora's role as a critical partner for manufacturers and healthcare providers while supporting long-term customer relationships.
The long-term demand backdrop also remains favorable. Industry forecasts project U.S. pharmaceutical spending to grow at an 8.2% CAGR through 2028, supported by rising prescription volumes, specialty therapies and broader patient access. Cencora is well positioned to benefit from sustained GLP-1 utilization, which contributed nearly $1.9 billion of year-over-year sales growth during the quarter despite moderating growth expectations.
International Business and Specialty Logistics Continue to Improve: Cencora's International Healthcare Solutions segment remained another bright spot. International revenues increased 13% year over year, while operating income rose 13.7%, driven by strong European distribution performance and a second consecutive quarter of operating income growth in global specialty logistics. Management highlighted new contract wins in cell and gene therapies, laboratory logistics and continued momentum at World Courier, reflecting improving execution in complex pharmaceutical logistics.
Key Challenges for COR StockRevenue Mix and Pricing Headwinds Could Pressure Reported Growth: Although prescription demand remains healthy, several factors continue to weigh on reported revenue growth. During the second quarter, manufacturer list price reductions created a roughly $2 billion revenue headwind, while faster-than-expected brand conversions at a large mail-order customer and slower GLP-1 growth prompted management to lower full-year revenue guidance. While these factors have a limited effect on operating income because they primarily involve lower-margin products, they can create volatility in reported sales growth and investor sentiment.
Higher Debt and Ongoing Regulatory Risks Remain Watch Points: The OneOncology acquisition has strengthened Cencora's specialty platform but also increased leverage. Net interest expense rose following the acquisition, and management expects approximately $485 million of interest expense in fiscal 2026 despite continued debt repayment efforts.
Beyond leverage, Cencora operates in a highly regulated pharmaceutical distribution environment. Ongoing opioid-related litigation exposure, controlled-substance monitoring requirements and evolving healthcare reimbursement policies could increase compliance costs or create operational challenges, even as the company continues investing in supply-chain integrity and regulatory compliance.
Estimate TrendCOR has been witnessing a stable estimate revision trend for fiscal 2026. In the past 30 days, the Zacks Consensus Estimate for earnings has remained stable at $17.79 per share.
The consensus mark for third-quarter fiscal 2026 revenues is pegged at $84.89 billion, indicating a 5.2% improvement from the year-ago reported actuals. The bottom-line estimate is pinned at $4.37, implying year-over-year growth of 9.2%.
Other Stocks to ConsiderSome other top-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Cardinal Health (CAH - Free Report) and McKesson (MCK - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
West Pharmaceutical has an estimated long-term earnings growth rate of 14.4%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 19.4%.
West Pharmaceutical’s shares have gained 29.2% against the industry’s 1.6% decline in the year-to-date period.
Cardinal Health has an estimated long-term earnings growth rate of 17%. CAH’s earnings surpassed estimates in the trailing four quarters, the average surprise being 10.3%.
Cardinal Health’s shares have risen 9.9% against the industry’s 1.6% decline in the year-to-date period.
McKesson has a long-term estimated growth rate of 13.7%. MCK’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 3.1%.
McKesson’s shares have edged up 0.5% against the industry’s 1.6% decline in the year-to-date period.
Top Analyst-Rated Healthcare Stocks to Watch NowTenet Healthcare NYSE: THC raised its full-year 2026 financial outlook after reporting second-quarter results that exceeded its expectations, supported by hospital volume growth, higher-acuity services, expense-management efforts and continued strength in its ambulatory surgery business.
Second-quarter net operating revenues totaled $5.6 billion, while consolidated adjusted EBITDA rose 16.3% from a year earlier to $1.304 billion. Adjusted EBITDA margin was 23.2%, and adjusted diluted earnings per share increased 52% year over year to $6.12.
Get Tenet Healthcare alerts:
3 Under-the-Radar Healthcare CompaniesChairman and Chief Executive Officer Dr. Saum Sutaria said the company’s first-half fundamental outperformance totaled approximately $97 million across its operating segments. “Hospital volumes and same-store revenue growth in both segments are strong,” Sutaria said, adding that margin performance benefited from technology-enabled expense initiatives implemented at the beginning of the year.
Guidance Raised for Revenue, EBITDA and Cash Flow For 2026, Tenet increased its consolidated net operating revenue outlook to a range of $21.9 billion to $22.5 billion, representing a $300 million increase at the midpoint from its previous forecast. The company raised adjusted EBITDA guidance to $4.83 billion to $5.03 billion, a $295 million increase at the midpoint.
HCA Healthcare: Temporary Setbacks, Long-Term StrengthManagement said the revised EBITDA outlook reflects roughly $100 million in fundamental outperformance during the first half and another $60 million from the expected continuation of those drivers in the second half. The company also cited contributions from ambulatory surgery acquisitions and supplemental Medicaid programs.
Adjusted free cash flow after noncontrolling interests is now projected at $1.825 billion to $2.055 billion, up $225 million at the midpoint. That outlook includes roughly $150 million of tax payments related to the Conifer transaction. Excluding those payments, the midpoint would be approximately $2.1 billion, Chief Financial Officer Sun Park said.
Hospital Segment Outperforms Despite Exchange Pressure Tenet’s hospital segment generated $762 million in adjusted EBITDA, up 22% from the second quarter of 2025, with an 18% adjusted EBITDA margin. Same-hospital inpatient adjusted admissions increased 2.6%, while revenue per adjusted admission rose 3.3% year over year.
Park said the revenue-per-admission increase reflected the company’s acuity strategy and higher supplemental Medicaid revenue, partly offset by lower exchange volumes. The company recognized $92 million of favorable out-of-period supplemental Medicaid revenue tied to prior years, compared with $70 million in the prior-year quarter. Park said Tenet would have recorded a “clean beat” even without the incremental Medicaid revenue.
Exchange revenue declined 17% from the second quarter of 2025 and accounted for about 5.5% of consolidated revenue during the quarter. Exchange admissions fell about 13.5%, according to Park, resulting in an approximately $65 million revenue headwind.
Management said the exchange decline was most pronounced in Florida, Arizona, Michigan, South Carolina and Texas. Park said the company saw exchange patients shift to uninsured status at a rate that was “pretty much one-to-one,” with uninsured volume increasing proportionately in the second quarter.
Tenet expects the exchange-market trends seen in the second quarter to continue through the rest of 2026 and did not change its assumptions for the back half of the year. Sutaria said the company has been adjusting its cost base while maintaining investments in growth initiatives.
USPI Emphasizes Higher-Acuity Procedures United Surgical Partners International, Tenet’s ambulatory surgery business, reported adjusted EBITDA of $542 million, an 8.8% increase from the prior-year quarter. Its adjusted EBITDA margin was 39%.
USPI same-facility systemwide revenue rose 5%, including a 6.3% increase in net revenue per case. Same-facility case volume declined 1.2%, which management attributed to its focus on higher-acuity care and the migration of lower-acuity procedures to office settings.
Sutaria highlighted 10% year-over-year same-store growth in total joint replacements at the company’s ambulatory surgery centers. He said USPI continues to expand into higher-acuity orthopedic procedures as well as urology, robotics, bariatrics and cardiovascular services. The company is also pursuing more complex procedures in established gastrointestinal and ophthalmology service lines.
Tenet now expects to spend more than $300 million on ambulatory surgery center mergers and acquisitions during 2026, reflecting transactions completed so far and its current pipeline of opportunities.
Cost Management and Capital Deployment In response to analyst questions, Sutaria outlined several components of Tenet’s cost-management strategy. These include traditional productivity measures, renegotiating purchased-service contracts and supply standardization, as well as clinical operating improvements involving length of stay, emergency department service levels, hospital throughput and operating-room and catheterization-lab scheduling.
The company is also using automation, artificial intelligence and its global business center to improve productivity and automate certain functions across payment operations and support structures, Sutaria said.
Tenet generated $444 million in adjusted free cash flow during the second quarter and $1.422 billion year to date. As of June 30, it had $2.17 billion of cash on hand, no outstanding borrowings under its revolving credit facility and no significant debt maturities until late 2027.
The company repurchased 5.7 million shares for $1.04 billion during the second quarter. First-half share repurchases totaled nearly 7 million shares, costing $1.36 billion. Tenet’s board authorized a further $2 billion increase to its share repurchase program, and management said it expects to remain active in buybacks through the remainder of the year.
Tenet reported a leverage ratio of 2.33 times EBITDA as of June 30, or 2.9 times EBITDA excluding noncontrolling interests. Management said capital priorities include ambulatory surgery acquisitions, hospital investments focused on higher-acuity services, share repurchases and potential debt retirement or refinancing.
About Tenet Healthcare (NYSE:THC)Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Tenet Healthcare Right Now?Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Both Eaton (ETN -1.76%)and nVent Electric (NVT -2.87%) are direct beneficiaries of the artificial intelligence (AI) data center and global electrification boom. Their revenue trajectories, however, reflect the contrast between an incumbent and a relatively smaller company trying to capture a bigger share of the market.
Eaton: A Steady Upward Revenue TrendEaton primarily generates revenue by providing energy-efficient solutions for electrical, hydraulic, and mechanical power across aerospace, vehicle, and other industrial segments.
While entering an agreement to separate its mobility group in June 2026, it reported a net margin of 12% for the quarter ended March 31, 2026.
nVent Electric: Consistent Quarter-Over-Quarter GainsnVent designs and produces electrical connection and protective equipment for commercial, industrial, and infrastructure applications.
It authorized a new share repurchase program and appointed new executive leadership in mid-2026, while reporting a net margin of 11% for the quarter ended March 31, 2026.
Why Revenue Matters for Retail InvestorsRevenue here refers to the data provider's standardized income statement revenue line item and serves as a baseline indicator of a company's ability to generate sales from its core business operations.
Quarterly Revenue for Eaton and nVent ElectricQuarter (Period End)Eaton RevenuenVent Electric RevenueQ2 2024 (June 2024)$6.3 billion$739.8 millionQ3 2024 (Sept. 2024)$6.3 billion$782.0 millionQ4 2024 (Dec. 2024)$6.2 billion$752.2 millionQ1 2025 (March 2025)$6.4 billion$809.3 millionQ2 2025 (June 2025)$7.0 billion$963.1 millionQ3 2025 (Sept. 2025)$7.0 billion$1.1 billionQ4 2025 (Dec. 2025)$7.1 billion$1.1 billionQ1 2026 (March 2026)$7.5 billion$1.2 billionData source: Company filings. Data as of July 13, 2026.
Foolish TakeEaton is a power management giant that designs and manufactures essential electrical distribution equipment, including transformers, circuit breakers, switchgear, substations, and uninterruptible power supply (UPS) systems. Its $9.5 billion acquisition of Boyd Thermal in March 2026 has given Eaton a huge headway into the rapidly growing liquid cooling market, creating one of the world’s largest grid-to-chip solutions providers.
Eaton’s revenue hit a record in Q1, with sales surging 17%, including 10% organic growth, 4% from Boyd and other acquisitions, and 3% from foreign exchange impact. Last quarter, Eaton raised its FY 2026 organic revenue guidance from 8% to 10% at the midpoint. Backlog as of the end of last quarter was $23 billion.
nVent Electric was spun off from Pentair (PNR +2.32%) in 2018 and has since doubled its sales. It does the work inside data centers, providing the electrical enclosures, cabinets, specialized racks, and thermal management solutions. Its steady revenue growth reflects strong demand.
nVent’s sales surged 51% year over year in Q1 to a record high, and it projects 2026 revenue growth of 26% to 28%. A backlog of $2.6 billion means nVent is almost 10 times smaller than Eaton, but it is growing faster. If you track the revenue trajectory, nVent could achieve higher percentage growth rates, as it’s a smaller company expanding its presence in data center cooling and connection infrastructure.
Look beyond the revenue growth, and both Eaton and nVent are solid AI plays right now.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Based in Los Angeles, Cathay General (CATY - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 29.22%. The holding company for Cathay Bank is currently shelling out a dividend of $0.38 per share, with a dividend yield of 2.43%. This compares to the Banks - West industry's yield of 2.42% and the S&P 500's yield of 1.33%.
Looking at dividend growth, the company's current annualized dividend of $1.52 is up 11.8% from last year. Over the last 5 years, Cathay General has increased its dividend 1 times on a year-over-year basis for an average annual increase of 2.11%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Cathay's current payout ratio is 31%, meaning it paid out 31% of its trailing 12-month EPS as dividend.
CATY is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $5.42 per share, which represents a year-over-year growth rate of 19.38%.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. However, not all companies offer a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. That said, they can take comfort from the fact that CATY is not only an attractive dividend play, but is also a compelling investment opportunity with a Zacks Rank of #2 (Buy).
New York, New York--(Newsfile Corp. - July 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Primoris Services Corporation (NYSE: PRIM) between August 5, 2025 and June 22, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 21, 2026.
SO WHAT: If you purchased Primoris common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Primoris class action, go to https://rosenlegal.com/cases/primoris-services-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 21, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Primoris' cost estimation, cost-to-complete forecasting, and project oversight processes were deficient and failed to provide reliable estimates of the costs and expected profitability of significant fixed-price renewable energy projects; (2) as a result, Primoris systematically underestimated the costs and risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (3) accordingly, defendants' statements regarding Primoris' estimating processes, project execution, ability to manage project risk, financial performance, and financial guidance lacked a reasonable basis and omitted material adverse facts. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Primoris class action, go to https://rosenlegal.com/cases/primoris-services-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306431
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming September 21, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) common stock between August 5, 2025 and June 22, 2026, inclusive (the “Class Period”).IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRIMORIS SERVICES CORPORATION (PRIM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Past performance is not an indicator of future performance. This post is illustrative and educational and is not a specific offer of products or services or financial advice. Information in this article is not an offer to buy or sell or a solicitation of any offer to buy or sell the securities mentioned herein. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Conagra Brands, Inc. remains a Buy, supported by a compelling portfolio, a strategic CEO transition, and an attractive valuation despite recent underperformance. The new CEO, John Brase, brings operational excellence and a clear mandate to simplify operations, raise prices, and focus on growth categories like frozen meals and meat snacks. The 50% dividend cut, while anticipated, strengthens CAG's balance sheet and supports long-term capital allocation priorities amid elevated leverage and margin pressures.
Zcash (ZEC) price hovers around $500 on Friday after five consecutive days of losses, testing a crucial support cluster. The privacy coin holds retail strength, with a positive funding rate despite over $2 million in liquidations over the last 24 hours, suggesting bullish bias persists. Technically, the easing bullish momentum risks a steeper decline below its 50-day Exponential Moving Average (EMA) around $489.
Retail demand in limboZcash derivatives witnesses firm retail demand despite a bullish positional wipeout. CoinGlass data shows a positive funding rate of 0.0076% on Friday, reflecting steady demand among traders to buy long positions at a premium despite a contraction in Open Interest (OI) and trading volume.
ZEC futures OI is down 3% over the last 24 hours to $998.72 million, with a 2% decline in trading volume to $1.27 billion, together suggesting an easing notional value of active positions as price drops and reduced retail activity.
However, the long liquidations of $1.64 million outpace short liquidations of $474,280 over the last 24 hours, indicating that bullish traders are facing margin calls. Despite the positional wipeout, the long-to-short ratio of 1.0245 suggests nearly equal active long and short contracts, although their weightings may differ.
Zcash derivatives data. Source: CoinGlassWill ZEC price hold above $500?Zcash tests a local support trendline near $500 on Friday, supported by the 50-day EMA at $489 and sits well over the 200-day EMA at $408. The privacy coin also trades above the 50% retracement of the recent downswing from $690 to $250, at $470, suggesting the broader uptrend is still intact despite the recent pullback.
From a technical perspective, Zcash is poised for a deeper correction below the $500 psychological mark. A sustained close below the 50-day EMA at $489 and 50% retracement at $470 could extend the decline to the 200-day EMA at $408.
That said, the Relative Strength Index (RSI) at 51 shows a downward trend toward the neutral midline as buying pressure wanes. At the same time, the Moving Average Convergence Divergence (MACD) crosses below its signal, hinting at renewed bearish pressure.
ZEC/USDT daily price chart.On the topside, immediate resistance emerges at the 78.6% Fibonacci retracement around $595, reinforced by the overhead trendline near $600. A sustained break above this level would open the way toward the prior swing high area near $690.
(The technical analysis of this story was written with the help of an AI tool. Know more.)
Zcash price has fallen toward the $500 psychological support as a 4-hour breakdown, leveraged liquidations, and caution before the Ironwood upgrade have weakened market sentiment.
Summary
Zcash price has fallen toward $500 after losing $520 and triggering more than $2 million in long liquidations. Bulls must reclaim $530 to neutralize the bearish structure, while $550 remains the main breakout level. A daily close below $477 could expose $466 and the rounded-top target near $371. According to data from crypto.news, Zcash (ZEC) price traded near $502 on July 24 after losing about 5.5% over the past week. Sellers took control after the token lost $520, while more than $2 million in long positions were liquidated over 24 hours. Automated stop orders added pressure once price slipped through intermediate support at $510.
Outside crypto, Thursday’s technology rout reduced demand for risk assets. The Magnificent Seven erased about $797 billion in market value after Alphabet and Tesla’s earnings raised concerns over heavy artificial intelligence spending. The Nasdaq Composite fell more than 2%, while Tesla dropped 14% and Alphabet lost almost 7%.
Oil and bond markets added another obstacle. Brent crude briefly moved above $100 after Houthi attacks on two Saudi tankers raised fears of disruption in the Red Sea. The 10-year U.S. Treasury yield reached an 18-month high near 4.70%, making speculative assets less attractive as traders reconsidered expectations for lower interest rates.
Crypto funds also lost institutional capital during the selloff. U.S. spot Bitcoin exchange-traded funds recorded $225 million in net outflows on July 23. BlackRock’s IBIT accounted for $202 million of the withdrawals, extending the defensive mood into altcoins such as ZEC.
Zcash price must reclaim $530 to repair its short-term structure On the daily chart, ZEC has fallen below its 20-day simple moving average at $514.77 but remains above the 50-day SMA at $477.05 and the 100-day SMA at $466.50. Those averages form the first major support area if bulls cannot hold $500. The 200-day SMA sits much lower at $382.96.
Zcash price daily chart — July 24 | Source: crypto.news Bear-bull power has dropped to minus 25.48, which shows that sellers have gained control after ZEC’s rejection near $570. However, the token remains above its medium- and long-term averages, leaving the daily recovery structure intact unless price closes decisively below the $466–$477 zone.
The 4-hour chart carries a more bearish setup. ZEC has formed a rounded-top structure since its July 15 peak near $580, with price now testing the $500 area. A confirmed breakdown could extend toward $470 before exposing the pattern’s main support and projected target around $370.69.
Zcash price has been forming a rounded-top pattern on the 4-hour chart — July 24 | Source: crypto.news Momentum readings have yet to confirm a reversal. The 4-hour Relative Strength Index stands at 35.11, close to oversold territory but still above 30. The Moving Average Convergence Divergence line remains below its signal line at minus 9.15 versus minus 8.65, while the negative histogram shows that sellers retain an advantage.
According to trader Ardi, $500 has become the main liquidity pivot after ZEC lost $520. The trader expects a brief move below the threshold before any sustained recovery and wrote:
“A reclaim of $530 would return the chart to neutral and likely begin a sideways consolidation phase.”
Ardi identified $550 as the level that would fully break the current bearish structure. Beyond it, $620 would become the next macro breakout barrier. Failure to protect $500, however, could force the trader to close the remaining long position established near $425.
CoinGlass’s three-day liquidation heatmap places the strongest overhead concentration between $524 and $529. A rebound into that band could force short sellers to exit and help ZEC challenge Ardi’s $530 neutral level. Below the market, another dense leverage pocket sits around $490–$494, making that range a likely destination if $500 gives way.
Zcash liquidation heatmap | Source: CoinGlass Derivatives traders have not turned fully bearish. ZEC’s funding rate remained positive at approximately 0.0076%, showing that long positions still pay shorts. Yet falling open interest and weaker spot volume show that fewer traders are willing to carry leverage through the current decline, limiting the fuel available for an immediate rebound.
Loss of $477 would invalidate the remaining bullish setup Ironwood, also known as NU6.3, will activate at block 3,428,143 on July 28. The upgrade will retire the vulnerable Orchard shielded pool and introduce a corrected pool. Funds leaving Orchard must pass through an accounting turnstile designed to prevent more ZEC from exiting than originally entered.
Zcash founder Zooko Wilcox has explained that the process cannot identify individual counterfeit coins or prove that the flaw was never exploited. Temporary wallet and exchange interruptions may occur as service providers update their systems, giving short-term traders another reason to reduce exposure before activation.
Zakura offers a longer-term counterweight to those concerns. The new Rust-based full-node client targets 50,000 private transactions per second and can reportedly start from a pruned snapshot in under two minutes. Still, the development has not stopped the current price correction.
A daily close below the 50-day SMA at $477.05 would weaken the primary recovery thesis and expose $466.50, followed by the June support region near $370. Continued ETF withdrawals, high Treasury yields, another oil spike, or complications during Ironwood activation would increase that downside risk. Bulls must first defend $500 and reclaim $530 before ZEC can make another attempt at $550.
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.